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REGULATION AND FUNCTION OF P2Y2 AND P2X 7 NUCLEOTIDE 
RECEPTORS IN THE CENTRAL NERVOUS SYSTEM 
Qiongman Kong 
Dissertation Supervisor: Dr. Gary A. Weisman 
ABSTRACT  
It is well known that ATP acts as a classic neurotransmitter in the central nervous 
system. It is stored in molar concentrations in synaptic vesicles, released upon 
neuronal excitation, and activates both ion channel receptors (P2X) and metabotropic 
receptors (P2Y) on post-synaptic cells. Activation of these nucleotide receptors then 
alters a variety of brain activities, such as the formation of long term memory and the 
perception of pain. In addition to its role as a neurotransmitter, ATP and other 
nucleotides are known to be released from injured or ischemic tissue and have been 
reported to affect inflammatory events in the brain and many other tissues, however, 
these inflammatory events as well as the subtype(s) of nucleotide receptor(s) 
influencing these events have not been well defined. This dissertation examines the 
expression patterns of P2X and P2Y nucleotide receptors in rat primary cortical 
neurons and adult rodent brain tissue. Based on these studies, particular emphasis was 
placed on delineating the role of the P2Y2 receptor subtype in neuronal inflammation 
and the P2X7 receptor subtype in neuronal apoptosis. 
The P2Y2 receptor is distinguished from other nucleotide receptor subtypes by an 
equal-potency for activation by ATP and UTP and its ability to be up-regulated in 
response to tissue injury or stress. Studies mentored by Dr. Cheikh Seye used a 
 xiii 
 
collared rabbit carotid artery model to indicate for the first time a role for the P2Y2R 
in development of intimal hyperplasia associated with atherosclerosis and restenosis 
(Appendix-1). In vitro studies with various cell lines (1321N1, HEK, COS7, and 
DITNC) in collaboration with others investigated signaling events regulated by the 
P2Y2R, including activation of PI3K, Src, calcium mobilization, Akt, and ERK1/2 and 
the importance of αVβ3/β5 integrin interaction with the P2Y2 receptor in selective (Go 
but not Gq) signaling and the antagonist role of BG0136 on P2Y2R activity 
(Appendix-2, 3). 
In a gerbil transient global ischemia model, we analyzed the effect of ischemia on 
the in vivo expression level of P2Y2R mRNA in the rodent brain by in situ 
hybridization and RT-PCR (Chapter 4). P2Y2R mRNA was expressed at low levels in 
normal rodent (rat, mouse and gerbil) brain. Transient ischemia (5 min occlusion) did 
not affect P2Y2R mRNA levels in any region of gerbil brain after various reperfusion 
times (4 h, 16 h and 48 h), indicating that the P2Y2R was not regulated at the 
transcriptional level in the gerbil transient ischemia model. 
The functional expression of the P2Y2R was also tested in rat primary cortical 
neurons (rPCNs). In rPCNs after in vitro culture for 7-10 days, P2Y2R mRNA and 
receptor activity were virtually absent in unstimulated cells, whereas overnight 
treatment with IL-1β caused up-regulation of both P2Y2R mRNA and receptor 
activity. Furthermore, activation of P2Y2R in rPCNs treated with IL-1β or transfected 
with P2Y2R cDNA enhanced the release of sAPPα, a secrectory amyloid protein that 
protects neurons as an injury-induced neurotrophic factor. P2Y2R-mediated sAPPα 
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release from rPCNs was dependent on ADAM10/17 and PI3K activity and was 
partially dependent on ERK1/2 activity, but did not require activation of PKC. These 
results suggest that under inflammatory conditions, IL-1β evokes functional 
up-regulation of P2Y2R in neurons and subsequent activation of the P2Y2R signaling 
cascade results in an increase of sAPPα release through activation of the α,γ-secretase 
pathway (Chapter 3).  
In contrast to the neuroprotective role of extracellular nucleotides just described, 
ATP has also been reported to cause apoptosis in a neuronal cell line by activating the 
P2X7 subtype of nucleotide receptors (P2X7R). Here, we extended the examination of 
P2X7R-mediated apoptosis in rPCNs. Unlike the P2Y2R, P2X7R was functionally 
expressed in unstimulated rPCNs (indicated by RT-PCR and ATP-induced 
intracellular calcium mobilization). Activation of the P2X7R via extracellular 
nucleotides in rPCNs caused biochemical (i.e., caspase activation) and morphological 
(i.e., nuclear condensation and DNA fragmentation) changes characteristic of 
apoptotic cell death through an intrinsic JNK1- and ERK-dependent caspase-8/9/3 
activation pathway (Chapter 2). 
Together, these data describe the expression patterns of P2 nucleotide receptors in 
rat primary cultures of cortical neurons, in adult rodent brains, in cerebral ischemia 
and in collared rabbit carotid arteries and demonstrate that the P2Y2R is up-regulated 
in response to cytokine stimulation in rPCNs and after collar transplantation around 
rabbit carotid arteries. Moreover, activation of the P2Y2R and P2X7R in rPCNs 
caused α-secretase-dependent APP processing and caspase8/9/3-dependent apoptosis, 
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respectively, whereas in vivo studies in the collared carotid artery model indicate that 
P2Y2R also plays an important role in the development of intimal hyperplasia.
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CHAPTER 1 
INTRODUCTION 
Adenosine 5’ –triphosphate release 
Nucleotides can be released from various sources in the nervous system include 
excitatory neurons, injured cells, cells undergoing mechanical or oxidative stress, 
aggregating platelets, degranulating macrophages, and astrocytes (Bergfeld et al., 
1992; Ciccarelli et al., 1999; Ahmed et al., 2000; Ostrom et al., 2001). In addition to 
acting as energy sources and neurotransmitters, purines such as adenosine 5’ 
–triphosphate (ATP) are trophic factors in both development/growth and 
regeneration/proliferation and neurotoxic factors in neuronal cell death of different 
cell types under normal physiological and developmental conditions (Burnstock and 
Wood, 1996; Neary et al., 1996; Vitolo et al., 1998). 
P2 nucleotide receptor classification 
Extracellular nucleotides bind to and activate cell surface P2 receptors. To date, 
these receptors have been classified into two main families: the G protein-coupled 
receptors (GPCRs; P2YR) and the ligand-gated ion channels (P2XR). Nine P2Y 
receptors have been cloned and identified as GPCRs with seven transmembrane 
domains coupled via G proteins (Gq/11 or Gi/o) to phospholipase C (PLC) and/or 
adenylate cyclase, including P2Y1, P2Y2, P2Y4, P2Y6, P2Y11, P2Y12, P2Y13, P2Y14, 
and P2Y15 (Sak and Webb, 2002; Inbe et al., 2004), although the P2Y15 receptor has 
not been conclusively established to be a P2 nucleotide receptor (Abbracchio et al., 
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2004). Seven P2X receptors have been cloned and identified as ligand-gated ion 
channels comprised of homo- or hetero-oligomers, including P2X1, P2X2, P2X3, P2X4, 
P2X5, P2X6, and P2X7 (Burstock 2000). Activation of these P2 receptor subtypes in 
neurons and glial cells under normal and pathological conditions can mediate cell 
apoptosis, proliferation, migration, inflammation, ion transport, and 
neurotransmission (Burstock 2000; Ciccarrelli et al., 2001). Therefore, P2 receptors in 
the CNS might be potential targets for pharmaceutical therapies in neurological 
disorders. Among these P2 receptors, our research has focused on the expression and 
regulation of the P2Y2R and its signaling pathways associated with 
α-secretase-dependent amyloid precursor protein (APP) processing, and on 
P2X7R-mediated apoptosis in neurons. 
Expression and regulation of P2 nucleotide receptors in the brain 
In the rat brain, P2Y1 receptor mRNA expression was detected and regulated at 
different embryonic and postnatal stages; P2Y2 receptor expression was detected at 
P8-12 (postnatal 8-12 days; Zhu and Kimelberg, 2004) and in adult rat brain (Loesch 
and Glass, 2006). P2Y4 receptor expression was detected at E14 (embryonic 14 days) 
and P8 (postnatal 8 days) while P2Y6 receptor expression was detected at E14 (Webb 
et al., 1998; Cheung et al., 2003; Zhu and Kimelberg, 2001 and 2004; Bennett et al., 
2003). P2Y12 receptor expression was low on E13 and E17, but it gradually increased 
during development from postnatal day 0 to 6 weeks (Sasaki et al., 2003). P2X3 
receptor mRNA was detected at E11, then declined in P7 rats, and was hardly 
detectable in P14 animals (Kidd et al., 1998; Cheung & Burnstock, 2002). Other P2X 
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receptor sybtypes were also detected at certain developmental stages. P2X1R 
expression was detected at P7, P2X2R expression was detected at E11 and P2X7 
receptor expression was detected at E19 (Kidd et al., 1995; Collo et al., 1997).  
In primary cultures of rat cortical astrocytes obtained at different postnatal 
periods, P2Y1, P2Y2, P2Y4 and P2X1-P2X4, P2X6, and P2X7 receptor subtypes were 
expressed in P1 pups (Lenz et al., 2000; Jacques-Silva et al., 2004); P2X3, P2X5-P2X7 
and P2Y1, P2Y2, P2Y4, and P2Y6 receptor expression was detectable in P2-P3 pups 
(postnatal 2-3 days; Figure 1A; Weisman et al., 2005); and all P2 receptor subtypes 
except P2X6 were detected in P7 pups (Fumagalli et al., 2003). In rat primary cortical 
neurons obtained at E17-19 days, mRNA for P2Y1, P2Y4, P2Y6, P2X3, P2X5, and 
P2X7 receptor subtypes were present after 7-10 days in culture, whereas very low 
levels of P2Y2, P2X2 and P2X6 receptor mRNA expression could be detected after 35 
cycles of polymerase chain reaction (Figure 1B-C; Weisman et al., 2005; Kong et al., 
2005). ATP and NGF have been shown to promote sustained up-regulation of various 
P2 nucleotide receptor subtypes including P2X2-P2X4 and P2Y2 in PC12 cells under 
neurite regenerating (serum-containing) conditions (Rathbone et al., 1999; 
D’Ambrosi et al., 2001).  
P2X7 nucleotide receptors and apoptosis 
As a mediator of cell-to-cell communication, ATP can trigger a variety of 
biological responses after being rapidly released in large amounts from various 
sources, including nerve terminals, activated glial cells, platelets, endothelial cells, 
antigen-stimulated T cells, and other cell types following hypoxia, stress, and tissue 
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damage. (Bergfeld et al., 1992; Ciccarelli et al., 1999; Ahmed et al., 2000; Ostrom et 
al., 2001) For example, in human umbilical cord vein endothelial cells (HUVECs), 
substantial release of ATP (and UTP) is induced by shear stress (Burnstock 1999), 
which may lead to alterations in the balance between proliferation and apoptosis 
regulated by P1 adenosine and P2 (particularly P2X7) nucleotide receptors (Kaiser et 
al., 1997). P2X7 and P1 receptors have been previously linked to apoptosis in other 
cell types, including immune cells, astrocytes, and thymocytes (Zheng et al., 1991; Di 
Virgilio et al., 1995; Jacobson et al., 1999). The P2X7R also has been shown to 
mediate ATP/UTP-induced cell death in human embryonic kidney cells (Wen et al., 
2003), human cervical epithelial cells (Wang et al., 2004), and primary rat cortical 
neurons (Chapter 2; Kong et al., 2005).  
In human fibroblasts, P2X7 receptors were identified as the main nucleotide 
receptor involved in high glucose concentration-dependent responses modulated by 
ATP, including morphological changes, enhanced apoptosis, caspase-3 activation, and 
IL-6 release (Solini et al., 2000). In the immune system, ATP also plays important 
roles through nucleotide receptors in leukocyte functions. P2X7 receptor-mediated cell 
death has been demonstrated in various cell types, including a lymphocytic cell line, 
murine thymocytes, murine peritoneal macrophages, human macrophages, mesangial 
cells, dendritic cells, and microglial cells (Zheng et al., 1991; Zanovello et al., 1990; 
Lammas et al., 1997; Schulze-Lohoff et al., 1998; Coutinho-Silva et al., 1999; Ferrari 
et al., 1999). It also has been reported that the P2X7 receptor modulates macrophage 
production of TNF-α, IL-1β and NO following LPS exposure (Hu et al., 1998), 
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consistent with a role for the P2X7 receptor in inflammation. These studies have 
provided compelling evidence suggesting a role for P2 receptors (especially P2X7R) 
in cell apoptosis in the central nervous system; however, further studies are needed to 
determine the precise pathways involved and to accumulate direct evidence that these 
pathways contribute significantly to neurodegenerative diseases and brain injury. 
Studies in Chapter 2 have investigated P2X7 receptor-mediated apoptosis in rat 
primary cortical neurons and the signaling pathways involved (Kong et al., 2005). 
P2Y2 nucleotide receptors in Alzheimer’s disease 
Alzheimer’s disease is an age-related neurodegenerative disorder that is 
characterized by progressive memory loss and deterioration of higher cognitive 
functions. The hallmarks of Alzheimer's disease (AD) include extracellular plaques of 
aggregated β-amyloid protein (Aβ) and intracellular neurofibrillary tangles that 
contain hyperphosphorylated tau protein in brain neurons (Figure 2; reviewed by 
Drouet et al., 2000). The senile plaques contain a compact deposition of β-amyloid 
peptides surrounded by dystrophic neuritis, activated microglia and reactive 
astrocytes. The major amyloid peptides in the plaques are Aβ1-42 and Aβ1-40, the 
4-kDa peptides derived by proteolytic cleavage of amyloid precursor protein (APP). 
APP can be cleaved within the Aβ domain by the combined action of α- and 
γ-secretases to generate neurotrophic and neuroprotective sAPPα and a P3 fragment 
(Li et al., 1997; Luo et al., 2001), or undergo cleavage by β- and γ-secretases to form 
neurodegenerative β-amyloid peptides (Aβ1-42 and Aβ1-40) (Younkin, 1998). Under 
normal conditions, about 90% of secreted Aβ peptides are Aβ1-40, a more soluble form 
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than Aβ1-42 that can be eliminated from brain and can only slowly be converted to the 
plaque-forming β-sheet configuration. In the AD brain, Aβ1-42 is first deposited in 
plaques, whereas Aβ1-40 is deposited later as the disease progresses (Iwatsubo et al., 
1994). A major goal to date in the development of treatments for AD include 
approaches that decrease Aβ production by blocking γ-secretase activity. However, 
this may result in defective haematopoiesis or other side effects (e.g., inhibition of the 
notch signaling pathway) due to loss of γ-secretase function (Rochette and Murphy, 
2002). Clearly, further studies are needed to better understand the regulation of the 
different APP processing enzymes (i.e., α-, β- and γ-secretases) to design effective 
treatments for AD.  
To date, the research on the functional involvement of P2 nucleotide receptors in 
AD is very limited. P2X7 receptors mediate superoxide production in primary 
microglia and are up-regulated in a transgenic mouse model of Alzheimer's disease 
(Parvathenani et al., 2003). Chronic neuroinflammation is a contributor to the 
pathophysiology of Alzheimer’s disease (AD; Eikelenboom et al., 2000; 
Hauss-Wegrzyniak et al., 1998). Oxidative stress and oligomeric β-amyloid (Aβ) 
peptide production in AD brain can increase extracellular levels of cytokines and 
nucleotides that activate receptors in glial cells (i.e., astrocytes and microglia) to 
stimulate intracellular signaling pathways and promote reactive gliosis, a universal 
response of the brain to injury (Mehlhorn et al., 2000). In the CNS, we reported that 
P2Y2 receptors mediate astrocyte migration through interactions with αV integrins in 
rat primary cortical astrocytes, which suggests a role for P2Y2R-mediated signaling in 
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regulating astrogliosis in brain disorders (Wang et al., 2005). Moreover, previous 
studies by our group showed that UTP enhances α- and γ-secretase-mediated APP 
processing in P2Y2R-transfected 1321N1 astrocytoma cells (Camden et al., 2005). 
However, relatively little is known about the contribution of P2Y2Rs to neuronal 
functions or their co-regulation with cytokine receptors of activities related to AD. 
Therefore, we have investigated the effect of cytokines on functional P2Y2R 
expression in primary cortical neurons from E18 rat embryos, as described in Chapter 
3. The role of P2Y2 receptors in APP processing and the signaling molecules involved 
was also investigated in rat primary cortical neurons (see Chapter 3). 
P2 nucleotide receptors in brain ischemia 
Acute ischemic stroke is the leading cause of adult disability and also the most 
frequent pathogenic mechanism of brain lesion in infancy (Guzzetta et al., 2000). 
Interestingly, basic and clinical evidence shows that impaired cerebral perfusion 
originating in the microvasculature triggered most of the key pathologic events 
associated with Alzheimer’s disease (AD); thus the presence of a condition that 
lowers cerebral perfusion together with advanced aging are proposed as two factors 
necessary to induce a neurodegenerative process in the AD brain (de la Torre, 2000).  
The cerebral circulation becomes inadequate under the following conditions that often 
lead to global ischemia, rather than focal ischemia: 1) the perfusion pressure is 
reduced; 2) the vascular resistance becomes too high; or 3) the oxygen or glucose 
supply is reduced (Garcia, 1975).Transient global ischemia caused by a 5-minute 
occlusion of gerbil bilateral carotid arteries (BCAOs) leads to selective and delayed 
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neuronal death (DND) of CA1 pyramidal neurons (Figure 3; Kirino, 1982), associated 
with activation of surrounding astrocytes in the hippocampus (DeLeo et al., 1987). 
Transient focal ischemia for 60 min consistently resulted in a large infarct confined to 
the right MCA cortex in rats (Figure 3C). However, ischemic stroke cannot be 
mimicked satisfactorily in vitro due to its complex pathophysiology involving the 
interplay of many different cells and tissues including neurons, glia, endothelium, and 
the immune system. Thus, several animal models of global and focal brain ischemia 
have been developed for stroke research including the gerbil/mouse model of transient 
global iscemia by occlusion of both common carotid arteries (CCAs) and the 
rat/mouse model of focal ischemia model by middle cerebral artery occlusion (MCAO) 
(Traystman, 2003).  
After transient global ischemia, up-regulation of P2X2 and P2X4 receptors was 
observed in neurons and microglia of gerbil hippocampus, respectively (Table 1; 
Cavaliere et al., 2003). P2X7 mRNA was also up-regulated in cultured cerebellar 
granule neurons of organotypic hippocampal cultures in vitro (Cavaliere et al., 2002, 
2004) and in activated microglia surrounding necrotic regions in vivo (Table 1; Collo 
et al., 1997), suggesting a role for P2X7Rs in the mechanisms of cellular damage 
induced by hypoxia/ischemia. Up-regulation of the P2Y2R subtype also has been 
found with stress and injury (Seye et al., 2002; Koshiba et al., 1997 and Turner et al., 
1997). For example, P2Y2R up-regulation is induced by a collar placed around a 
rabbit carotid artery (Seye et al., 2002) and arterial P2Y2R up-regulation is associated 
with enhanced neointimal hyperplasia, macrophage infiltration and osteopontin 
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expression in response to UTP (Seye et al., 1997, 2003, 2004 & 2006). These findings 
indicate for the first time a role for the P2Y2R, in development of intimal hyperplasia 
associated with atherosclerosis and restenosis (Seye et al., 2002; Appendix-1). In 
Chapter 4, the expression of P2Y2 receptors was identified in normal adult rodent 
brains and the relationship of P2Y2 receptor expression to ischemia-induced injury 
was determined in a gerbil transient ischemia model (Weisman et al., 2005; Chapter 
4). 
Outline of the dissertation 
This dissertation contains five parts concerning the Regulation and Function of 
P2Y2 and P2X7 Nucleotide Receptors in the Central Nervous System from (i.e., 
Chapters 2-4 and the Appendix). 
In Chapter 2, we examined P2X7R-mediated apoptosis in rat primary cortical 
neurons (rPCNs). P2X7Rs were functionally expressed in the rPCNs and their 
activation by extracellular nucleotides was shown to cause apoptotic cell death 
through an intrinsic JNK1- and ERK-dependent caspase-8/9/3 activation pathway. 
Chapter 3 extends the examination of nucleotide receptors in rPCNs to the P2Y2 
receptor subtype. P2Y2R mRNA and receptor activity were virtually absent in 
unstimulated rPCNs but was dramatically up-regulated upon overnight treatment with 
IL-1β. Furthermore, activation of P2Y2R in rPCNs enhanced the release of sAPPα, a 
putative neuroprotective secrectory amyloid protein, by an ADAM10/17- and 
PI3K/ERK-dependent mechanism.  
In Chapter 4, the expression pattern of P2Y2 receptor was studied in adult rodent 
 9 
 
brain slices. Moreover, the effect of ischemia on the expression level of P2Y2Rs in the 
rodent brain was analyzed by in situ hybridization and RT-PCR in a gerbil transient 
global ischemia model. 
This dissertation concludes with Chapter 5, which addresses future directions and 
the scientific significance of the completed research followed by an Appendix that 
presents data from other projects undertaken. 
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Table 1. Regulation of P2 nucleotide receptor expression after ischemia and in 
Alzheimer’s Disease (AD) 
 
P2R Injury Cell type Change
P2X2 Ischemia Neurons (hippocampus, organotypic culture, gerbil) ↑ 
P2X4 Ischemia Microglia (hippocampus, organotypic culture, gerbil) ↑ 
Ischemia Microglia (cortex, rat) ↑ 
Ischemia Neurons (hippocampus, organotypic culture) ↑ 
Ischemia Astrocytes, neurons, microglia (cortex, rat) ↑ 
 
 
P2X7
AD Around plaques (hippocampus, Tg2576 mice) ↑ 
 
P2Y1
 
AD 
Neurofibrillary tangles, neuritic plaques, neuropil 
threads (human hippocampus)  
Cellular distribution pattern was altered in AD brains. 
↓ 
 
(Collo et al., 1997; Moore et al., 2000; Cavaliere et al., 2003 &2004; Parvathenani et 
al., 2003 ; Franke et al., 2004 ; modified from review in Franke and Illes, 2006b) 
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Figure 1. Expression of P2 receptors in rat cortical astrocytes and neurons. Total 
RNA was isolated from primary rat cortical (A) astrocytes or (B, C) neurons and 
RT-PCR was used to amplify mRNAs to P2Y and P2X receptors, as previously 
described (Weisman et al., 2005; Kong et al., 2005).  The amplified PCR products 
were resolved by gel electrophoresis, and data shown are representative of results 
from three independent experiments performed in the presence (+) or absence (-) of 
reverse transcriptase (only the +RT samples are shown in (A) and ++ indicates 
amplification of a G3PDH-positive control sample (B). 
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Figure 2. Nerve cells, synapses and brain tissue in Alzheimer’s disease. A. 
Alzheimer’s disease tissue has fewer nerve cells and synapses than healthy brain 
tissue and there are abnormal clusters of phosphorylated tau protein in dead and dying 
neurons (white arrow) surrounded with Aβ plaques (white circles) in the extracellular 
space. B. In advanced Alzheimer’s disease, most of the cortex is seriously damaged. 
The brain shrinks dramatically due to widespread cell death. Pictures are cited from: 
www.alz.org. 
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(Cited from www.alz.org) 
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Figure 3. Neuronal cell death in rodent ischemia models. A, B: transient gerbil 
global cerebral ischemia, Toshiki et al., 2005; and C: rat focal cerebral ischemia, 
web.psych. ualberta.ca/~fcolbour/research.html. Neuronal densities in the CA1 region 
of the gerbil hippocampus (B) dramatically decreased 5 days after transient cerebral 
ischemia compared with the sham-operated gerbil brain (A). Arrows show location of 
changes. Focal cerebral ischemia–reperfusion injury induced by temporary middle 
cerebral artery occlusion (MCAO) for 60 min followed by reperfusion causes a large 
infarct (C; top of right cortex) compared with the sham-operated right MCA cortex.
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(A-B: Toshiki et al., 2005; C: ) web.psych.ualberta.ca/~fcolbour/research.html
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CHAPTER 2  
 
 
P2X7 NUCLEOTIDE RECEPTORS MEDIATE CASPASE-8/9/3-DEPENDENT 
APOPTOSIS IN RAT PRIMARY CORTICAL NEURONS 
Kong, Q. et al., (2005) Purinergic Signalling 1:337-347 
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ABSTRACT 
Apoptosis is a major cause of cell death in the nervous system. It plays a role in 
embryonic and early postnatal brain development and contributes to the pathology of 
neurodegenerative diseases. Here, we report that activation of the P2X7 nucleotide 
receptor (P2X7R) in rat primary cortical neurons (rPCNs) causes biochemical (i.e., 
caspase activation) and morphological (i.e., nuclear condensation and DNA 
fragmentation) changes characteristic of apoptotic cell death. Caspase-3 activation 
and DNA fragmentation in rPCNs induced by the P2X7R agonist BzATP were 
inhibited by the P2X7R antagonist oxidized ATP (oATP) or by pretreatment of cells 
with P2X7R antisense oligonucleotide indicating a direct involvement of the P2X7R in 
nucleotide-induced neuronal cell death. Moreover, Z-DEVD-FMK, a specific and 
irreversible cell permeable inhibitor of caspase-3, prevented BzATP-induced 
apoptosis in rPCNs. In addition, a specific caspase-8 inhibitor, Ac-IETD-CHO, 
significantly attenuated BzATP-induced caspase-9 and caspase-3 activation, 
suggesting that P2X7R-mediated apoptosis in rPCNs occurs primarily through an 
intrinsic caspase-8/9/3 activation pathway. BzATP also induced the activation of 
JNK1 and ERK1/2 in rPCNs, and pharmacological inhibition of either JNK1 or 
ERK1/2 significantly reduced caspase activation by BzATP. Taken together, these 
data indicate that extracellular nucleotides mediate neuronal apoptosis through 
activation of P2X7Rs and their downstream signaling pathways involving JNK1, ERK 
and caspases 8/9/3. 
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INTRODUCTION 
ATP is an important extracellular messenger generated from various sources 
including release from presynaptic vesicles upon nerve stimulation in the peripheral 
and central nervous systems (Burnstock et al., 1978). Extracellular ATP functions as a 
neuromodulator by activation of cell surface P2 nucleotide receptors that are widely 
expressed in the nervous system (Burnstock 1980; Inoue 2002). Based on their 
distinct structure, P2 nucleotide receptors are classified into two families: G 
protein-coupled P2Y receptors (P2YR1, 2, 4, 6, 11-14; Abbracchio et al., 2003) and 
ligand-gated ion channels (P2XR1-7; Burnstock 2000). Functional responses to 
activation of these P2 receptor subtypes in cells of the nervous system under normal 
and pathological conditions include cell apoptosis, proliferation and migration, 
inflammation, ion transport, and neurotransmission (Burnstock 2000; Norenberg & 
Illes 2000; von Kugelgen & Wetter 2000; Khakh 2001 and Illes et al., 2004). 
Therefore, P2 receptors in the nervous system may prove to be useful pharmaceutical 
targets in the treatment of neurological disorders.  
The seven subtypes of the ionotropic ATP-gated P2XR family, ranging from 379 
to 595 amino acids in length, regulate the intracellular calcium concentration through 
ligand-stimulated increases in the cell membrane permeability to extracellular Ca2+ 
ions (Benham 1990; Di Virgilio et al., 2001a). In contrast to other P2XRs, the P2X7R 
subtype functions exclusively as a homomeric receptor (Chessell et al., 1998; North & 
Surprenant 2000). The P2X7R is a 595-amino acid polypeptide containing two 
membrane-spanning domains, a large extracellular loop, and intracellular N- and 
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C-terminal domains including a C-terminal tail that is the longest among the cloned 
P2XRs (Surprenant et al., 1996; Rassendren et al., 1997). P2X7Rs have been reported 
in microglial cells (Collo et al., 1997) where they play a role in cytokine release 
(Ferrari et al., 1997). These receptors are also found in cultured astrocytes and 
Schwann cells (Duan et al., 2003; Grafe et al., 1999), spinal cord neurons and in other 
regions of the central nervous system (Deuchars et al., 2001; Atkinson et al., 2004). 
Brief stimulation of the P2X7R with ATP results in formation of a non-selective 
cationic channel that promotes the influx of Ca2+ and the equilibration of the 
transmembrane sodium and potassium gradients leading to membrane depolarization 
(Surprenant et al., 1996; Rassendren et al., 1997; Weisman et al., 1984; Virginio et al., 
1999). Subsequent responses to P2X7R activation include the formation of a 
nonselective pore for molecules up to 900 Da (Weisman et al., 1984; Virginio et al., 
1999), extensive membrane blebbing, and eventual cell death (Virginio et al., 1999). 
Activation of the P2X7R was reported to elicit Ca2+ influx in cerebrocortical nerve 
terminals (Lundy et al., 2002) and hippocampal glutamate release (Sperlagh et al., 
2002), which has been confirmed by studies with P2X7R knockout mice (Papp et al., 
2004). In an ex vivo model of organotypic hippocampal cultures, P2X7R activation 
was shown to directly participate in cell damage induced by oxygen/glucose 
deprivation (Cavaliere et al., 2004). It has been shown that a Pro-451 to Leu 
polymorphism within the C-terminal tail of the P2X7R interferes with the ability of 
the receptor to induce cell death in murine thymocytes (Le Stunff et al., 2004). The 
P2X7R also has been shown to mediate ATP-induced cell death in human embryonic 
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kidney cells (Wen et al., 2003) and human cervical epithelial cells (Wang et al., 2004). 
A recent study demonstrated that spinal cord injury was associated with prolonged 
P2X7R activation of spinal cord neurons by extracellular ATP, which resulted in 
high-frequency spiking, increases in cytosolic calcium levels and neuronal 
degeneration, responses that were reversed by P2X7R inhibition (Wang et al., 2004).  
In the present study, we demonstrate that the P2X7R agonists BzATP or ATP 
induce nuclear condensation and DNA fragmentation in rat primary cortical neurons 
(rPCNs). These apoptotic responses in rPCNs were dependent on the functional 
expression of P2X7Rs that mediate the ERK1/2- and JNK1-dependent activation of 
caspases-8/9/3. 
MATERIALS AND METHODS  
Materials  
Fetal bovine serum (FBS) was obtained from Hyclone (Logan, UT, USA). 
Dulbecco’s Modified Eagle’s Medium (DMEM), Minimum Essential Medium 
(MEM), Neurobasal Medium, penicillin (100 units/ml), streptomycin (100 units/ml) 
and B27-AO (B27 without cortex antioxidants) were obtained from Gibco-BRL 
(Carlsbad, CA, USA). Rabbit anti-rat ERK1/2, horseradish peroxidase 
(HRP)-conjugated goat anti-rabbit IgG, and HRP-conjugated goat anti-mouse IgG 
antibodies were obtained from Santa Cruz Biotechnology (Santa Cruz, CA, USA). 
Goat anti-rat P2X7R antibody was obtained from Alomone (Jerusalem, Israel). Rabbit 
anti-rat caspase-8 antibody was obtained from Biovision Inc. (Mountain View, CA, 
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USA). Mouse anti-NeuN antibody was obtained from Chemicon International Inc. 
(Temecula, CA, USA). Alexa Fluor TM 488 goat anti-mouse IgG antibody, Alexa 
Fluor TM 594 goat anti-rabbit IgG antibody, YO-PRO-1, TO-PRO-3 and the Prolong 
anti-fade kit were obtained from Molecular Probes Inc. (Eugene, OR, USA). All other 
antibodies were obtained from Cell Signaling Technology (Beverly, MA, USA). 
Caspase-3 and caspase-9 inhibitors were obtained from R&D (Minneapolis, MN, 
USA). Caspase-8 inhibitor was obtained from BioSource International Inc. (Camarillo, 
CA, USA). The Precision Plus Protein Standards and nitrocellulose membranes (0.45 
mm) were obtained from Bio-Rad (Hercules, CA, USA). LumiGLO 
chemiluminescent substrates were obtained from New England Biolabs (Beverly, MA, 
USA). The RNeasy Mini Kit was obtained from Qiagen (Chatsworth, CA, USA). The 
Apoptotic DNA-ladder kit, the First Strand cDNA Synthesis kit and the TUNEL In 
Situ Cell Death Detection kit were obtained from Roche (Indianapolis, IN, USA). 
Nucleotides and all other biochemicals were obtained from Sigma Chemical Co. (St. 
Louis, MO, USA). 
Primary cell culture of cortical neurons 
Experimental procedures for cell culture of rat primary cortical neurons (rPCNs) 
were carried out essentially as described by Suen et al. (Suen et al., 2003). Briefly, 
cerebral cortices from18-day-old embryos of Sprague-Dawley rats were removed and 
the meninges discarded. The brain tissue was mechanically dissociated in HGGMEM 
comprised of 1.78 g glucose, 100 IU/ml penicillin, 100 μg/ml streptomycin, 7.5 μg/ml 
fungizone, 2 mM glutamine in 88 ml of MEM and 10% (v/v) horse serum. The tissue 
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clumps were dispersed with a 10 ml pipette and suspended in 6 ml of 0.25% (w/v) 
trypsin at 37 °C for 10 min. After incubation, 2 ml of heat-inactivated horse serum 
were added to block trypsin activity. Cells were centrifuged at 4000 g for 5 min and 
the pellet was suspended in HGGMEM with 10% horse serum. The cell suspension 
was filtered through a sterilized 75 mm cell strainer (nylon membrane; Becton 
Dickinson, Franklin Lakes, NJ) and cells were counted and seeded into plastic culture 
plates that were precoated with poly-D-lysine (0.1 μg/ml). After 16 h and every 3 
days thereafter, the medium was replaced with B27-AO Neurobasal Medium (2 mM 
glutamine, 8.9 g glucose, 100 IU/ml penicillin, 100 μg/ml streptomycin, 7.5 μg/ml 
fungizone, 10 ml of B27 minus AO, and Neurobasal Medium (Gibco-BRL) to 500 ml) 
and the neurons were ready for use after 7 days in culture. 
RT-PCR analysis of P2XR mRNA expression 
Total RNA was isolated from rPCNs using the RNeasy Mini Kit (Qiagen). cDNA 
was synthesized from the purified RNA using the First Strand cDNA Synthesis Kit 
for RT-PCR (AMV) (Roche). Five percent of the synthesized cDNA was used as a 
template in PCR reactions with the Expand High Fidelity PCR System (Roche). 
Specific oligonucleotide primers were designed to selectively amplify cDNA for 
individual P2XR subtypes, as shown in Table 2. The amplification was performed 
using 35 cycles of denaturation at 95 °C for 30 s, with annealing at 60 °C for 30 s and 
extension at 72 °C for 1 min. The resulting PCR products were resolved on a 1% (w/v) 
agarose gel containing 10 mg/ml ethidium bromide and photographed under UV 
illumination. 
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Single cell calcium assay 
The [Ca2+]i was quantified in single cells with the Ca2+-sensitive fluorescent dye 
fura-2, using an InCyt Dual-Wavelength Fluorescence Imaging System (Intracellular 
Imaging, Cincinnati, OH). Rat PCNs cultured on a poly-D-lysine-coated coverslip 
were incubated with 2.5 μM fura-2-acetoxymethylester at 37 °C for 30 min in 
physiological salt solution (PSS) containing (mM) NaCl 138, KCl 5, CaCl2 2, MgCl2 
1, HEPES 10, glucose 10, pH 7.4, and washed with PSS. The coverslip with 
fura-2-loaded cells was positioned on the stage of an inverted epifluorescence 
microscope (Nikon; model TMD) and stimulated with agonists at 37 °C, as described 
in the figure legends. Cells were exposed to 340/380 nm light and fluorescence 
emission at 505 nm was converted to [Ca2+]i using a standard curve created with 
solutions containing known concentrations of Ca2+. Increases in [Ca2+]i were 
measured by subtracting basal [Ca2+]i from the maximum agonist-induced increase in 
[Ca2+]i. The percentage of cells that responded to ATP/BzATP was also determined. 
Viable cells were identified by responsiveness to carbachol and non-responding cells 
were eliminated. 
Detection of nuclear condensation 
Rat PCNs were cultured in B27-AO Neurobasal medium on poly-D-lysine-coated 
coverslips in 12-well plates until 50-70% confluence. After nucleotide treatments, 
medium was removed and cells were washed once and incubated with 
DAPI-methanol staining solution (1 mg/ml) for 15 min at 37 °C. The staining solution 
was removed and the cells were washed with methanol. The inverted coverslip was 
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placed onto a microscope slide using glycerol as the mounting agent. Nuclear 
morphology was observed under a fluorescence microscope (Nikon, Eclipse TE300) 
with a 340/380 nm excitation filter and a LP 430 nm barrier filter. DAPI has an 
absorbance maximum at 340 nm and an emission maximum at 488 nm in aqueous 
solution (Kapus’cin’ski et al., 1978). 
DNA laddering assay 
Rat PCNs were cultured in B27-AO Neurobasal medium in 100 mm dishes to 
70% confluence, and incubated in serum-free medium overnight with or without 
BzATP, or treated for 2 h with 500 μM H2O2 and DNA was isolated using the 
Apoptotic DNA-ladder kit (Roche, Indianapolis, IN) according to the manufacturer’s 
instructions. DNA also was isolated from lyophilized apoptotic U937 cell lysate 
(provided with the DNA-ladder assay kit) for use as a positive control. Briefly, the 
medium was replaced with 200 μl of PBS and 200 μl of binding buffer (6 M 
guanidine-HCl, 10 mM urea, 10 mM Tris-HCl, pH 4.4, 20% (v/v) Triton X-100). 
After 10 min at 15-25 °C, 100 ml of isopropanol were added and the samples were 
transferred to a filter tube and centrifuged for 1 min at 10,000 g (Spectrafuge Labnet, 
Edison, NJ). The fluid in the collection tube was discarded and the upper filter column 
was washed with 500 μl of washing buffer (20 mM NaCl and 2 mM Tris-HCl, pH 7.5, 
40% (v/v) ethanol) followed by centrifugation twice for 1 min at 13,000 g. After the 
residual washing buffer was removed, the DNA was eluted with 200 μl of 
pre-warmed (70 °C) elution buffer (10 mM Tris, pH 8.5). The concentration and 
purity of the eluted DNA was determined by measuring the optical density at 260 and 
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280 nm. DNA was electrophoresed in a 2% (w/v) agarose gel at 80 V for 1 h in TBE 
buffer (89 mM Tris base, 89 mM boric acid, 2 mM EDTANa2-salt, pH 8.3) and 
visualized under UV light. 
TUNEL assay 
After treatment with nucleotides or H2O2, rPCNs were fixed with fresh 4% (v/v) 
paraformaldehyde in PBS and treated with 3% (v/v) H2O2 in methanol to inhibit 
endogenous peroxidase activity. Then, DNA strand breaks in fixed cells were detected 
with a TUNEL In Situ Cell Death Detection kit (Roche) according to the 
manufacturer’s instructions. The number of TUNEL-positive cells and the total cell 
number were determined by fluorescence (Nikon; Eclipse TE300) using an excitation 
wavelength in the range of 450-500 nm and a detection wavelength in the range of 
515-565 nm (green) and light microscopy with cell counting, respectively, at 200x 
magnification. 
Application of P2X7 antisense oligonucleotide  
Antisense oligonucleotide treatment was performed as previously described (Seye 
et al., 2002). Phosphorothioate-modified oligonucleotides to rat P2X7 were 
synthesized and purified by Integrated DNA Technologies (ADT, Coralville, IA, 
USA). Sequences were designed as follows: sense 5’-AGAGCGTGAATTACGGCA 
CATCAA-3’, antisense 5’-TTGATGGTGCCGTAATTCACGCTCT-3’. Sequences 
were checked for uniqueness with the National Center for Biotechnology 
Information’s Basic Local Alignment Search Tool (http://www.ncbi.nlm.nih. 
gov/BLAST). The rPCNs were incubated with 0.1 or 1 μmol/L P2X7 sense or 
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antisense S-oligonucleotide for 6 h in serum-free medium containing 1.4% (v/v) 
DOTAP liposomal reagent (Roche Diagnostics). Fresh serum-free medium was added 
with or without BzATP, and cells were cultured for an additional 18 h. 
Western blot analysis 
Rat PCNs cultured in 6-well plates were treated with 300 μM BzATP in the 
presence or absence of inhibitors as indicated. The cells were washed twice with 
ice-cold PBS, and lysed for 5 min in 200 ml of ice-cold lysis buffer (20 mM Tris-HCl, 
pH 7.5, 2% (w/v) sodium dodecyl sulfate (SDS), and 1 mM sodium orthovanadate). 
Lysate (30 mg of protein) was added to Laemmli sample buffer (187.5 mM Tris-HCl, 
pH 6.8, 6% (w/v) SDS, 1.8% (v/v) β-mercaptoethanol and 0.003% (w/v) 
bromophenol blue). Samples were heated for 5 min at 96-100 °C, and subjected to 
7.5% (w/v) SDS-polyacrylamide gel electrophoresis (SDS-PAGE) and transferred to 
nitrocellulose membranes for protein immunoblotting. After overnight blocking at 4 
°C with 5% (w/v) fat-free milk in TBS-T (10 mM Tris-HCl, pH 7.4, 120 mM NaCl, 
and 0.1% (v/v) Tween-20), membranes were incubated with either 1:1000 dilution of 
anti-ERK1/2, anti-phospho-ERK1/2, anti-phospho-JNK, or anti-P2X7R antibodies for 
2 h at room temperature, or 1:1000 dilution of anti-cleaved caspase-3, anti-caspase-3, 
anti-cleaved caspase-9, anti-caspase-9, or anti-caspase-8 antibodies overnight at 4 °C 
followed by incubation with HRP-conjugated anti-rabbit or anti-mouse IgG antibodies 
(1:1000 dilution in TBS-T containing 5% (w/v) fat-free milk) for 1 h at room 
temperature. For normalization of protein loading, the membranes were stripped of 
antibodies by incubation for 30 min at 60 °C in stripping buffer (62.5 mM Tris-HCl, 
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pH 6.8, 100 mM 2-mercaptoethanol, and 2% (w/v) SDS), and re-probed with 1:2000 
dilution of rabbit polyclonal anti-actin antibody (2 h at room temperature; 
Cytoskeleton, Denver, CO) followed by 1:2000 dilution of HRP-conjugated 
anti-rabbit IgG antibody (1 h at room temperature). Protein immunoreactivity was 
visualized on autoradiographic film using the LumiGlo Chemiluminescence System 
(New England BioLabs), according to the manufacturer’s instructions. The protein 
bands detected on X-ray film were quantified using a computer-driven scanner and 
Quantity One software (Bio-Rad, Hercules, CA). The activation levels of kinases or 
caspases were calculated as a percentage of control (i.e., total kinase, caspase, or 
actin). 
Immunofluorescence 
After fixation and permeabilization, rPCNs cultured on coverslips in 6-well plates 
were incubated in 2.5% (w/v) BSA and 2.5% (v/v) goat serum in PBS for 1 h at room 
temperature followed by incubation overnight with mouse anti-NeuN antibody (1:100 
dilution; Chemicon) and rabbit anti-cleaved caspase-3 antibody (1:100 dilution; Cell 
Signaling) in 0.25% BSA and 0.25% goat serum in PBS. Cells were washed three 
times with PBS and then incubated with 1:200 dilution of goat anti-mouse Alexa 
Fluor 488- or goat anti-rabbit Alexa Fluor 594-conjugated IgG antibody (Molecular 
Probes, Eugene, OR) in 0.25% BSA and 0.25% goat serum in PBS for 1 h at 37 °C. 
Nuclei were stained with TO-PRO-3 (Molecular Probes), cells were rinsed with PBS 
and mounted on glass slides in ProLong antifade reagent (Molecular Probes). Images 
were obtained on a Bio-Rad MRC 1024 laser scanning confocal imaging system 
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coupled to an Olympus IX70 inverted microscope. The imaging system was 
controlled by Laser Sharp software (version 3.2; Bio-Rad, Hercules, CA). Alexa 
488-labeled slices were excited by 488 nm laser light, and images were acquired with 
a 522 nm emission filter with a bandwidth of 35 nm, whereas Alexa 594-labeled 
slices were excited by 568 nm light and images acquired with a 585 nm longpass 
emission filter. Settings of the confocal microscope were optimized for imaging in an 
initial experiment and then equivalently applied to all sections. Laser power and 
photomultiplier tube (PMT) gain were adjusted to ensure that even the brightest 
fluorescence was below saturation levels. Neurons were randomly chosen and 
scanned at 512 x 512 pixel resolution. 
Statistical analysis 
Results are expressed as the means ± S.E.M. Statistical analysis of data was 
performed using Graph Pad Prism version 4.0. Statistical significance was determined 
by student t-test. Differences were considered statistically significant when p < 0.05. 
RESULTS  
Purity of rat cortical neurons in primary culture  
The purity of rPCNs was determined by monitoring morphology with phase 
contrast microscopy and by immunofluorescence assay with the neuron-specific 
marker NeuN and the nuclear stain, TO-PRO-3 (Figure 1A). NeuN staining was found 
primarily in the nucleus of the neurons with lighter staining in the cytoplasm. About 
95% of the cells were determined to be cortical neurons based on the ratio of NeuN 
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positive cells to total cells counted by TO-PRO nuclear staining (data not shown). 
Functional P2X7Rs are expressed in rat PCNs 
Rat PCNs express P2X7R mRNA, as well as mRNAs for P2X2, P2X3, P2X5, and 
P2X6 receptors (Figure 1B). Furthermore, immunoblot analysis indicated that rPCNs 
express P2X7R protein (Figure 1C). The P2X7R agonists ATP and BzATP (Erb et al., 
1990) caused a dose-dependent increase in [Ca2+]i in rPCNs (Figure 2), suggesting 
that calcium influx is stimulated by activation of the endogenously expressed P2X7R 
protein. Calcium responses were also observed by stimulation of rPCNs with 
2-methylthio-ADP (data not shown), an agonist of the P2Y1R, indicating that other 
P2R subtypes besides the P2X7R can regulate increases in [Ca2+]i.  
ATP and BzATP induce nuclear condensation and DNA fragmentation in rPCNs 
Treatment of rPCNs with either BzATP (300 μM) or ATP (100 μM) overnight 
caused nuclear condensation as indicated by increased DAPI staining of nuclei 
(Figure 3). BzATP-induced nuclear condensation was inhibited by the P2X7R 
antagonist oATP, consistent with the involvement of P2X7Rs in this process. 
Moreover, BzATP treatment of rPCNs caused DNA fragmentation, suggestive of 
apoptotic cell death (Figure 4). BzATP or ATP also caused DNA strand breakage in 
rPCNs, another indicator of apoptosis, detected as an increase in the number of 
TUNEL-positive cells (Figure 5). These data suggest that BzATP or ATP can cause 
apoptosis in rPCNs through a pathway involving P2X7R activation. 
P2X7R-mediated caspase-3 and caspase-9 activation 
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Caspase-3 is an essential component of apoptotic pathways in many cell types, 
including neurons (Salvesen and Dixit, 1997), and is activated by the sequential 
release of cytochrome c from mitochondria and the activation of caspase-9 (Li et al., 
1997). Consistent with a role for caspase-3 in nucleotide-induced neuronal apoptosis, 
nuclear condensation caused by BzATP was diminished by treatment of rPCNs with 
the caspase-3 inhibitor Z-Asp(OMe)-Glu(OMe)-Val-Asp(OMe)-FMK (Z-DEVDFMK; 
Figure 3C). Results also indicated that treatment of rPCNs with either ATP or BzATP 
significantly increased the cleavage of caspase-3 in a time- and dose-dependent 
manner (Figure 6A). BzATP-induced caspase-3 cleavage was inhibited by oATP 
(Figure 6B), the caspase-3 inhibitor Z-DEVD-FMK (Figure 6B), or P2X7 antisense 
oligonucleotide (Figure 6C). Although recent studies indicate that oATP might act 
independently from P2 receptor inhibition (Beigi et al., 2003), inhibition of 
BzATP-induced caspase-3 cleavage by P2X7R antisense oligonucleotide confirms the 
involvement of the P2X7R. Since no preparation of primary neurons is devoid of glial 
cells, dual immunofluorescence analysis for neuron-specific NeuN and cleaved 
caspase-3 was performed to evaluate whether the apoptotic cells were neurons. The 
majority of cells treated with BzATP were positive for cleaved caspase-3 and NeuN 
(e.g., pink and white arrows in Figure 6D), indicating that a large percentage of cells 
undergoing apoptosis were neurons. NeuN immunoreactivity has been reported to 
decrease under several pathological conditions (Unal-Cevik et al., 2004), and 
therefore NeuN detection may decrease with caspase-3 activation in apoptotic neurons, 
suggesting that some apoptotic neurons may go undetected. BzATP also caused the 
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cleavage of caspase-9 (Figure 7A), whereas activation of caspase-9 and caspase-3 
were significantly inhibited by the caspase-8 inhibitor Ac-IETD-CHO (Figure 7B) or 
the caspase-9 inhibitor Z-LEHD-FMK (data not shown), indicating that caspase-8 
also plays a role in activating downstream caspase family members (e.g., caspase-9/3) 
of the P2X7R-mediated apoptosis pathway. We also detected an inhibitory effect of 
the caspase-9 inhibitor, Z-LEHD-FMK, on caspase-8 cleavage (Figure 7C) suggesting 
that caspase-8 and caspase-9 may regulate caspase-3 activity in a non-linear fashion. 
Caspase-3 activation by BzATP in rPCNs is dependent upon ERK1/2 and JNK1 
phosphorylation 
P2X7R-mediated activation of extracellular signal-regulated kinases (ERK1/2) in 
rat primary astrocytes (Panenka et al., 2001) and SAPK/JNK in human and rodent 
macrophages occur independently of the activation of caspase-1- or caspase-3-like 
proteases (Humphreys et al., 2000). Here, we tested whether ERK1/2 or JNK1 
activities were involved in BzATP-induced apoptosis in rPCNs. As indicated in 
Figure 8, both ERK1/2 and JNK1 were rapidly phosphorylated in response to BzATP 
or ATP in a dose- and time-dependent manner. Inhibition of ERK1/2 or JNK1 
phosphorylation in rPCNs with either the MEK inhibitor UO126 or the JNK inhibitor 
SP600125, respectively, attenuated caspase-3 activation, indicating the involvement 
of ERK1/2 and JNK1 in BzATP-induced neuronal cell death (Figure 9). 
DISCUSSION  
The results obtained with rat PCNs indicate that activation of the P2X7R by its 
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agonists BzATP or ATP promotes the cleavage of caspases-8/9/3 and the appearance 
of cellular markers indicative of apoptosis including DNA degradation and nuclear 
condensation and fragmentation. Since BzATP can activate other P2X receptor 
subtypes, albeit at higher concentrations than the P2X7R (Bianchi et al., 1999), we 
explored the role of the P2X7R in the apoptotic effects of BzATP in rPCNs using 
P2X7 antisense oligonucleotide to downregulate P2X7R expression and the P2X7R 
antagonist oATP. Results indicate that inhibition of P2X7R activity significantly 
inhibited BzATP-induced nuclear condensation (by P2X7R antagonist oATP; Figure 3) 
and caspase-3 cleavage (by both oATP and P2X7R antisense oligonucleotide; Figure 
6), apoptotic responses that were diminished by incubation of rPCNs with the 
caspase-3 inhibitor, Z-DEVD-FMK (Figures 3C and 6B). These data strongly suggest 
that P2X7Rs mediate BzATP-induced apoptosis in rPCNs, although this does not rule 
out a potential role for other P2 nucleotide receptors.  
P2X7R-mediated neuronal apoptosis in vivo requires that ATP be released from 
neurons or non-neuronal cells to activate cell surface receptors on neighboring 
neurons. Neuronal P2X7 receptors are targeted to presynaptic terminals in the central 
and peripheral nervous systems and activation of the P2X7R has been indicated to 
promote release of vesicular contents from presynaptic terminals (Deuchars et al., 
2001). ATP is present at high concentrations in synaptic vesicles and is released as a 
co-transmitter with noradrenaline, acetylcholine and other neurotransmitters 
(Burnstock et al., 1978). ATP release also has been demonstrated in a model of spinal 
cord injury (Sim et al., 2004). Thus, ATP release from excited neurons or damaged 
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cells is an assumed consequence of any brain injury or disease (e.g., ischemia, spinal 
cord injury, or neurodegenerative diseases), suggesting that pro-apoptotic P2X7Rs are 
likely activated under pathological conditions in vivo. Recent research indicates a lack 
of P2X7R expression in adult rat hippocampal neurons (Khera et al., 2004), whereas 
our studies demonstrate functional P2X7R expression in rPCNs from 18-day old 
embryos. We have detected P2X7R mRNA in freshly isolated rPCNs (data not shown) 
and 7-10 day-old cultures (Figure 1), suggesting that the in vitro cell culture 
procedure alone was not required for P2X7R expression.  
Caspase activation is known to play a central role in the execution of apoptosis by 
causing nuclear condensation, DNA fragmentation and other apoptotic changes. In the 
mitochondrial-initiated pathway of apoptosis, caspase activation is triggered by the 
formation of a multimeric Apaf-1/cytochrome c complex that is fully functional in 
recruiting and activating procaspase-9 (Li et al., 1997). Activated caspase-9 will then 
cleave and activate downstream caspases such as caspase-3, -6, and -7. In rPCNs, it 
was not surprising that activation of caspase-3 was significantly inhibited by the 
caspase-9 inhibitor Z-LEHD-FMK (data not shown), since caspase-9 is known to 
activate caspase-3. We also found that in rat PCNs, the caspase-8 inhibitor 
Ac-IETD-CHO partially inhibited caspase-9 and caspase-3 activation (Figure 7B) 
indicating that caspase-8 cleavage may be an early event in this neuronal apoptosis 
pathway. Caspase-8 has been reported to play a role in cytochrome c-dependent 
apoptosis (Viswanath et al., 2001) and caspase-8 activation is associated with Fas 
receptor-induced apoptosis (Zhuang et al., 1999) and can result in the cleavage and 
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activation of Bid, a proapoptotic member of the Bcl-2 family (Li et al., 1998). 
Truncated Bid translocates from the cytoplasm to the mitochondria, where it appears 
to antagonize the actions of anti-apoptotic Bcl-2, thereby causing an efflux of 
cytochrome c from the mitochondria and downstream caspase-9/3 activation (Li et al., 
1998; Kuwana et al., 1998; Luo et al., 1998; Schendel et al., 1999; Wei et al., 2001). 
In human embryonic kidney HEK-293 cells expressing P2X7Rs, extracellular ATP 
induced apoptosis associated with activation of poly (ADP-ribose) polymerase (PARP) 
and a decrease in Bax protein expression (Wen et al., 2003). We examined the effect 
of ATP/BzATP on the expression of Bcl-2 family members in rPCNs but failed to 
detect a significant change in Bax and Bcl-2 protein expression (data not shown). 
Evidence from cell-free and in vitro expression systems has indicated that caspase-3 
can induce cleavage and activation of the upstream initiator caspase-8 (Slee et al., 
1999; Wolf and Green, 1999; Tang et al., 2000). Our data indicated that inhibition of 
caspase-9 cleavage decreased caspase-8 cleavage (Figure 7C), consistent with the 
ability of downstream caspases to regulate the cleavage of initiator caspases. 
We have demonstrated that activation of P2X7Rs in rPCNs increases calcium 
influx (Figure 2) and stimulates phosphorylation of the intracellular kinases ERK1/2 
and JNK1 (Figure 8). Furthermore, inhibition of ERK1/2 or JNK1 phosphorylation 
decreased BzATP-induced caspase-3 cleavage (Figure 9). Our previous studies 
demonstrating that P2X7R-mediated ERK1/2 activation was dependent on 
extracellular Ca2+ (Gendron et al., 2003) suggest a similar role for BzATP-stimulated 
calcium influx in rPCNs (Figure 2). Recent studies indicate that activation of ERK 
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and phosphatidylinositol 3-kinase/Akt signaling pathways caused inhibition of 
caspase-3 and cell apoptosis (Khreiss et al., 2002). It also has been reported that 
inhibition of MEK/ERK signaling is required for the induction of apoptosis by 
Sulindac metabolites (Rice et al., 2004). Nonetheless, our data support the hypothesis 
that ERK1/2 and JNK1 activation can promote P2X7R-mediated apoptosis in rPCNs, 
although the mechanism involved requires further investigation. P2X7Rs can promote 
neuronal cell death by mediating the release of glutamate and inflammatory factors 
from cortical neurons, RAW 264.7 macrophages, and astrocytes (Duan et al, 2003; 
Hu et al., 1998; Guerra et al., 2003). Moreover, glutamate can induce ATP release 
from astrocytes (Queiroz et al., 1999), suggesting that ATP and glutamate have 
reciprocal roles that contribute to the propagation of an apoptotic signal. It also has 
been reported that the P2X7R modulates macrophage production of TNF-α, IL-1β and 
nitric oxide (NO) following LPS exposure (Hu et al., 1998), consistent with a role for 
the P2X7R in inflammation (Di Virgilio et al., 2001b). In addition to these factors, 
structural features within the P2X7R indicate that the mechanism whereby it regulates 
apoptosis is likely to be complex. There are several functional domains located in the 
P2X7R C-terminal tail including an LPS-binding domain, a SH3-binding domain, and 
an overlapping Fcelldeath domain, which appear to be important for receptor 
trafficking and various physiological functions (Denlinger et al., 2001), and the role 
of these domains in P2X7R-mediated apoptosis of neurons warrants further 
investigation. Our studies with the membrane impermeant fluorescent dye YO-PRO-1 
(molecular weight: 375 Da) indicate that BzATP causes pore formation (YO-PRO-1 
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uptake) in rPCNs (data not shown), consistent with the report that apoptosis in the 
retinal microvasculature is associated with P2X7 receptor-mediated pore formation 
(Sugiyama et al., 2004). 
A recent study indicated that spinal cord neurons expressed an abundance of 
P2X7Rs, and exposure of freshly prepared spinal cord slices to ATP or BzATP evoked 
high frequency firing and irreversible increases in the cytosolic Ca2+ concentration 
(Wang et al., 2004). Significant cell death occurred 24 h after spinal cord injury in 
areas of high ATP release surrounding the epicenter of the injury, while local 
injection of oATP in the peritraumatic zone strongly reduced both apoptotic cell 
number and the severity of histological injury, suggesting the involvement of a P2X7R. 
Other studies indicate that the P2X7R is up-regulated in a mouse model of 
Alzheimer’s disease (Parvathenani et al., 2003). Thus, the P2X7R may represent a 
promising therapeutic target to inhibit neurodegeneration due to injury or disease. 
In summary, the data presented indicate that BzATP and ATP can stimulate 
P2X7Rs in embryonic rat primary cortical neurons leading to the activation of the 
caspases-8/9/3 and the induction of DNA degradation and nuclear condensation and 
fragmentation, apoptotic responses that appear to be regulated by ERK1/2 and JNK1. 
Since neuronal apoptosis occurs in Alzheimer’s disease, Parkinson’s disease and other 
neurodegenerative disorders, a better understanding of the mechanisms of 
P2X7R-mediated apoptosis may lead to novel therapies to prevent apoptosis-related 
brain injuries.
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Table 2.   Sequence-specific oligonucleotide primers used for RT-PCR studies. 
 
Receptor Subtypes Oligonucleotide Sequences  
  Forward 5'-AAC AGC ATC AGC TTT CCA CG-3'
P2X1
  Reverse 5'-TGT AGT AGT GCC TCT TAG GC-3'
  Forward 5'-ACC TGC CTC TCC GAC GCC GA-3'
P2X2
  Reverse 5'-GAA GTC AGA GCT GTG GCC AG-3'
  Forward 5'-CAA CTT CAG GTT TGC CAA A-3' 
P2X3
  Reverse 5'-TGA ACA GTG AGG GCC TAG AT-3' 
  Forward 5'-TAC GAC ACG CCG CGC ATC-3'
P2X4
  Reverse 5'-TGC ACG ATT TGA GGT AGG ACG-3' 
  Forward 5'-CAA AGT CCA TGC CAA CGG AT-3'
P2X5
  Reverse 5'-ACG GAA CTC TAC CCC ATT AG-3'
  Forward 5'-GTA GTG CTG TGC CCA GGA AA-3'
P2X6
  Reverse 5'-GGA CTC CAC GCC TGA GGC TG-3'
  Forward 5'-ACA ATG TTG AGA AAC GGA CTC TGA-3' 
P2X7
  Reverse 5'-CCG GCT GTT GGT GGA ATC CAC ATC-3'
  Forward 5’-TGA AGG TCG GTG TCA ACG GAT TTG GC-3’
G3PDH 
  Reverse 5’-CAT GTA GGC CAT GAG GTC CAC CAC-3’ 
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Figure 1. Purity of rat primary cortical neurons (rPCNs) and P2X7R expression. 
(A) Rat PCNs were cultured on coverslips in 6-well plates and neurons were labeled 
with mouse NeuN monoclonal antibody (Panel a) and cell nuclei with TO-PRO-3 
(Panel b); merged picture shown in Panel c. (B) RNA was isolated from rPCNs 
maintained in culture for 7-10 days and RT-PCR was used to amplify mRNAs to 
P2X1-7Rs, as described in the “Materials and Methods”. The amplified PCR products 
were resolved by gel electrophoresis, and data shown are representative of results 
from three independent experiments. Results are shown of PCRs performed in the 
presence (+) or absence (-) of reverse transcriptase (RT). G3PDH primers were used 
to amplify G3PDH mRNA as a positive control. (C) P2X7R protein expression was 
detected by Western blot analysis, as described in the “Materials and Methods”. 
Human 1321N1 cells expressing the recombinant human P2X7R or the empty 
expression vector pLXSN were used as positive (+) or negative (-) controls, 
respectively. Precision Plus Protein Standards are indicated as ‘75KD’ and ‘100KD’. 
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Figure 2. ATP- and BzATP-induced increases in [Ca2+]i in rat PCNs. (A) Single 
cell calcium assays were performed on rPCNs that were cultured for 7-10 days on 
poly-D-lysine-coated coverslips. Cells were incubated in PSS with the indicated 
concentration of BzATP or ATP and the maximum increase in [Ca2+]i was determined, 
as described in the “Materials and Methods”. (B) The percentage of cells responding 
to BzATP or ATP is shown as the mean +/- S.E.M. of results from three experiments.  
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Figure 3. ATP/BzATP-induced nuclear condensation mediated by the P2X7R is 
dependent on caspase-3 activation.  (A) Rat PCNs were cultured for 7-10 days, 
incubated in serum-free HGGMEM for 6 h and stimulated with BzATP (300 μM) or 
ATP (100 μM) for 16 h or with H2O2 (1 mM) for 2 h. When indicated, 500 μM oATP 
was added 2 h prior to addition of BzATP. Cells cultured in B27-AO Neurobasal 
medium (NB) or in serum-free HGGMEM (-) overnight were used as controls. Then, 
nuclear condensation was determined by DAPI staining and detected by fluorescence 
microscopy, as described in the “Materials and Methods”. (B) Cells were treated as in 
(A) except that the data were expressed as a percentage of cells that exhibited DAPI 
stained nuclei. Data are the means +/- S.E.M. of results from at least four experiments, 
where *p < 0.05, and ***p < 0.001 indicate significant differences from the 
serum-starved control (-), and where ###p < 0.001 indicates a significant difference 
from BzATP treatment. (C) rPCNs were treated as in (A) except that 10 μM 
Z-DEVD-FMK, a caspase-3 inhibitor, was added for 1 h prior to BzATP, when 
indicated.  
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Figure 4. BzATP stimulates DNA fragmentation in rat PCNs. Rat PCNs were 
incubated in serum-free HGGMEM for 6 h and then stimulated with BzATP (300 μM) 
for 16 h or H2O2 (1 mM) for 2 h. Cells cultured in serum-free HGGMEM (-) 
overnight were used as the control. Then, cells were lysed, total DNA was purified, 
the DNA concentration was determined, and 3 μg of purified DNA was loaded onto 
each lane of a 2% (w/v) agarose gel and electrophoresed, as described in the 
“Materials and Methods”. DNA fragmentation was visualized after electrophoresis of 
DNA. Apoptotic U937 cells (+++; provided in the Apoptotic DNA-ladder kit) were 
used as a positive control and “M” indicates the 100 bp DNA ladder marker.
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Figure 5. BzATP or ATP induces DNA strand breakage in rat PCNs. Rat PCNs 
were cultured for 7-10 days, incubated in serum-free HGGMEM for 6 h, and 
stimulated with BzATP (300 μM) or ATP (100 μM) for 16 h or with H2O2 for 2 h. 
Cells cultured in serum-free HGGMEM (-) overnight were used as the control. Then, 
cells were fixed and DNA strand breakage was determined by TUNEL assay, as 
described in the “Materials and Methods”. DNA strand breakage was observed as 
green fluorescence using fluorescence microscopy.   
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 Figure 6. P2X7Rs mediate caspase-3 activation in rat PCNs. (A) Rat PCNs were 
incubated in serum-free medium for 6 h and then stimulated with the indicated 
concentration of ATP or BzATP for 16 h or the time indicated. Cells cultured in 
B27-AO Neurobasal medium (NB) or in serum-free HGGMEM (-) overnight were 
used as controls. (B) Cells were treated as in (A) except that 500 μM oATP was added 
for 2 h or the indicated concentration (1, 10 or 100 μM) of Z-DEVD-FMK was added 
for 1 h prior to addition of 300 μM BzATP for 16 h. (C) Cells were treated as in (A) 
except that P2X7 antisense or sense oligonucleotide was added at the indicated 
concentration in μg/ml for 8 h prior to addition of 300 μM BzATP for 16 h or 1 mM 
H2O2 for 2 h. Western analysis was performed to determine the relative amounts of 
caspase-3, cleaved caspase-3 or P2X7R protein. Data are the means +/- S.E.M. of 
results from at least three experiments, where *p < 0.05, **p < 0.01, and ***p < 0.001 
indicate significant differences from either serum-starved (A) or BzATP-treated (B, C) 
cells.  (D) Rat PCNs were serum-starved overnight in the presence (Panels B, D and 
F) or absence (Panels A, C, and E) of 300 μM BzATP and then immunofluorescence 
of the neuron-specific marker NeuN (green; Panels A, B), cleaved caspase-3 (red; 
Panels C and D), and the nuclear stain TO-PRO (blue; Panels E and F) were detected 
as described in the “Materials and Methods”. Arrows (pink or white) indicate 
apoptotic neurons that are both capase-3 and NeuN positive, whereas yellow arrows 
indicate apoptosis in a NeuN-negative cell. Similar results were obtained in three 
individually isolated groups of primary cultures. 
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Figure 7. Role of caspase-8 and caspase-9 in P2X7R-mediated apoptosis in rPCNs. 
(A) Rat PCNs were incubated in serum-free HGGMEM and BzATP (300 μM) was 
added for 16 h. Cells cultured in B27-AO Neurobasal medium (NB) or in serum-free 
HGGMEM (-) overnight were used as controls. (B) Cells were treated as in (A) 
except that the indicated concentration (μM) of a specific caspase-8 inhibitor, 
Ac-IETD-CHO was added for 1 h prior to addition of 300 μM BzATP. (C) Cells were 
treated as in (B) except that the indicated concentration of a specific caspase-9 
inhibitor, Z-LEHD-FMK, was added. “Pan” (full-length) and cleaved caspase-8 were 
detected by Western analysis, as described in the “Materials and Methods”. Data are 
the means +/- S.E.M. of results from at least three experiments, where *p < 0.05, **p 
< 0.01, and ***p < 0.001 indicate significant differences from either serum-starved (A) 
or BzATP-treated (B, C) cells.  
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Figure 8. BzATP or ATP induces ERK1/2 and JNK1 phosphorylation in rPCNs. 
Rat PCNs were incubated in serum-free HGGMEM for 6 h and treated with the 
indicated concentration (μM) of BzATP or ATP for 5 min or with 100 μM ATP or 300 
μM BzATP for the indicated time period. Cells cultured in serum-free HGGMEM (-) 
overnight were used as the control. Then, cell lysates were prepared and (A) ERK1/2 
or (B) JNK1 phosphorylation was detected by Western analysis, as described in the 
“Materials and Methods”. Total ERK1/2 and actin were used as protein loading 
controls for (A) and (B), respectively. 
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Figure 9. Inhibitors of MEK and JNK decrease BzATP-induced caspase-3 
cleavage in rat PCNs.  Rat PCNs were incubated in serum-free HGGMEM for 6 h 
and treated for 30 min with the indicated concentration (μM) of (A) the MEK 
inhibitor U0126, (B) the JNK inhibitor SP600125 or (A, B) 0.1% (v/v) DMSO as a 
vehicle control. Then, the cells were incubated with 300 μM BzATP for 16 h, and 
Western analysis was used to detect expression of cleaved or pan caspase-3, as 
described in the “Materials and Methods”. Cells cultured in serum-free HGGMEM (-) 
overnight were used as the control.  Data are the means +/- S.E.M. of results from at 
least three experiments, where *p < 0.05, **p < 0.01, and ***p < 0.001 indicate 
significant differences from BzATP-treated cells.  
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CHAPTER 3 
 
 
 
IL-1β ENHANCES NUCLEOTIDE-INDUCED α-SECRETASE-DEPENDENT 
APP PROCESSING IN RAT PRIMARY CORTICAL NEURONS VIA 
UPREGULATION OF THE P2Y2 RECEPTOR 
Kong, Q. et al., to be submitted
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ABSTRACT 
The P2Y2 nucleotide receptor (P2Y2R) stimulates α-secretase-dependent 
cleavage of the amyloid precursor protein (APP) in human 1321N1 astrocytoma cells, 
causing extracellular release of the neuroprotective protein sAPPα. In this study, we 
analyzed functional upregulation of the P2Y2R by cytokines and the P2Y2 
receptor-mediated production of sAPPα in rat primary cortical neurons (rPCNs). In 
rPCNs, P2Y2R mRNA and receptor activity were virtually absent in unstimulated 
cells, whereas overnight treatment with the inflammatory cytokine IL-1β upregulated 
both P2Y2R mRNA expression and receptor activity. Furthermore, the P2Y2R agonist 
UTP enhanced the release of sAPPα in rPCNs treated with IL-1β or transfected with 
P2Y2R mRNA. UTP-induced release of sAPPα from rPCNs was completely inhibited 
by pretreatment of the cells with the metalloproteinase inhibitor TAPI-2 or the PI3K 
inhibitor LY2904, partially inhibited by the MEK inhibitor U0126, and unaffected by 
the PKC inhibitor GF109203, suggesting that P2Y2R-mediated release of sAPPα from 
neurons is dependent on ADAM10/17 and PI3K activity, partially dependent on 
ERK1/2 activity, and does not require activation of PKC. These results suggest that 
under inflammatory conditions, IL-1β evokes the functional upregulation of the 
P2Y2R in neurons and implicates the activation of the P2Y2R in neuroprotection. 
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INTRODUCTION 
Inflammation is established as a central component of several chronic diseases. 
Various inflammatory mediators, such as cytokines, chemokines, proteases and 
protease inhibitors, have been detected in the AD brain (Parihar and Hemnani, 2004). 
Interleukin-1 (IL-1) and tumor necrosis factor α (TNF-α) are rapidly upregulated in a 
variety of tissues in response to pro-inflammatory stimuli to amplify downstream 
signaling cascades that mediate inflammation (Cacquevel et al. 2004). In Alzheimer’s 
disease, IL-1 directly regulates the expression and processing of β-amyloid precursor 
protein (β-APP), the phosphorylation of tau and the increased production and activity 
of acetylcholinesterase (AChE) in neurons. These processes result in neuronal stress 
and injury, which in turn further enhance microglial activation and IL-1 
overexpression in a self propagating cycle. Recent studies, however, indicate that 
certain aspects of the inflammatory response may have therapeutic potential 
(Wyss-Coray et al., 2001). Nucleotides co-released with neurotransmitters can 
activate a widely distributed family of nucleotide receptors in the CNS. P2 nucleotide 
receptors (i.e., P2X ion channels and G protein-coupled P2Y receptors) have been 
implicated in the regulation of numerous functions in the mammalian nervous system, 
including neurotransmission, glial cell migration, cell proliferation, ion transport, 
neuronal cell apoptosis and survival (Burnstock, 2000; Ciccarelli et al., 2001; 
Weisman et al., 2005). The P2Y2 nucleotide receptor is distinguished among other P2 
receptors by its ability to be activated equipotently by ATP and UTP and has been 
shown to be upregulated in response to stress or injury in various cell types, including 
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activated thymocytes, salivary gland epithelial cells, and models of vascular tissue 
injury (Koshiba et al., 1997; Turner et al., 1997; Seye et al., 2002). In rat primary 
cortical astrocytes, the P2Y2R is functionally expressed and promotes astrocyte 
migration through receptor interaction with αV integrins, which suggests an important 
role for P2Y2R-mediated signaling pathways in regulating astrogliosis in brain 
disorders (Wang et al., 2005). However, very little is known about the functional role 
of the P2Y2 nucleotide receptor subtype in neurons.  
Previously, we demonstrated that the G protein-coupled P2Y2R mediates the 
α-secretase-dependent release of sAPPα from human 1321N1 astrocytoma cells 
(Camden et al., 2005). Cleavage of APP by α-secretase results in the shedding of 
nearly the entire ectodomain of APP to yield a large soluble derivative called sAPPα, 
and essentially precludes the generation of neurotoxic Aβ peptide. Several zinc 
metalloproteinases, including TNF-α converting enzyme (TACE/ADAM17), 
ADAM9, ADAM10 and MDC-9, and the aspartyl protease BACE2 can cleave APP 
at the α-secretase site (Allison et al., 2003). While the proteolytic cleavage of APP is 
constitutive, it can also be increased by substances such as GPCR agonists that 
activate protein kinase C (PKC) or other signaling pathways (Nitsch et al., 1997; 
Kirazov et al., 1997) and may function in the modulation of neuronal excitability, 
synaptic plasticity, neurite outgrowth, synaptogenesis, and cell survival (Mattson, 
1997).  
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The aim of this study was to determine whether cytokines such as IL-1β regulate 
functional expression of the P2Y2R in rat primary cortical neurons and how P2Y2R 
signaling pathways affect APP processing in these cells.  
 
MATERIALS AND METHODS 
Materials  
Fetal bovine serum (FBS) was obtained from Hyclone (Logan, UT). Dulbecco’s 
Modified Eagle’s Medium (DMEM), Minimum Essential Medium (MEM), 
Neurobasal Medium, penicillin (100 units/ml), streptomycin (100 units/ml) and 
B27-AO (B27 without cortex antioxidants) were obtained from Gibco-BRL (Carlsbad, 
CA). Rabbit anti-rat ERK1/2, horseradish peroxidase (HRP)-conjugated goat 
anti-rabbit IgG, and HRP-conjugated goat anti-mouse IgG antibodies were obtained 
from Santa Cruz Biotechnology (Santa Cruz, CA). Rabbit anti-rat beta amyloid 
antibody was obtained from Signet Laboratories (Dedham, MA). All other antibodies 
were obtained from Cell Signaling Technology (Beverly, MA). The Dual Color 
Protein Standards and nitrocellulose membranes (0.45 mm) were obtained from 
Bio-Rad (Hercules, CA). LumiGLO chemiluminescent substrates were obtained from 
New England Biolabs (Beverly, MA). The RNeasy Mini Kit was obtained from 
Qiagen (Chatsworth, CA). The First Strand cDNA Synthesis Kit and the PCR Kit 
were obtained from Roche (Indianapolis, IN). The GenCarrierTM2 Transfection 
Reagent Kit was obtained from Epoch Biolabs (Sugar Land, TX). Nucleotides and all 
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other biochemicals were obtained from Sigma Chemical Co. (St. Louis, MO). 
Primary cell culture of cortical neurons 
Experimental procedures for cell culture of rat primary cortical neurons (rPCNs) 
were carried out as previously described (Kong et al., 2005). Briefly, cerebral cortices 
from 18-day-old embryos of Sprague-Dawley rats were removed and the meninges 
were discarded. The brain tissue was mechanically dissociated in HGDMEM 
comprised of DMEM, 10% (v/v) FBS, 2 mM glutamine, 100 IU/ml penicillin, 100 
mg/ml streptomycin, and 7.5 mg/ml fungizone. The tissue clumps were dispersed with 
a 10 ml pipette and suspended in 6 ml of 0.25% (w/v) trypsin at 37 °C for 10 min. 
Then, 2 ml of heat-inactivated horse serum were added to neutralize trypsin activity. 
The cell suspension was centrifuged at 900 g for 5 min and the cell pellet was 
suspended in HGDMEM. The resulting cell suspension was filtered through a 
sterilized 75 mm cell strainer (Becton Dickinson, Franklin Lakes, NJ) and the cells 
were seeded into plastic culture plates precoated with poly-D-lysine (0.1 μg/ml). After 
16-18 h and every 3 days thereafter, the medium was replaced with B27-AO 
Neurobasal Medium (2 mM glutamine, 100 IU/ml penicillin, 100 mg/ml streptomycin, 
7.5 mg/ml fungizone, 10 ml of B27-AO, and Neurobasal Medium (Gibco-BRL) to 
500 ml) and 15 μg/ml 5-fluoro-2’-deoxyuridine was added to retard glial cell 
proliferation. The neurons were used for experiments after 7 days in culture (DIV7). 
RT-PCR analysis of P2Y2R mRNA expression  
Total RNA was isolated from rPCNs using the RNeasy Mini Kit (Qiagen). cDNA 
was synthesized from the purified RNA using the First Strand cDNA Synthesis Kit 
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for RT-PCR (AMV; Roche). Five percent of the synthesized cDNA was used as a 
template in PCR reactions with the Expand High Fidelity PCR System (Roche). 
Specific oligonucleotide primers were designed to selectively amplify cDNA for 
P2Y2R and G3PDH, as previously described (Wang et al., 2005). The amplification 
was performed using 35 cycles for P2Y2R and 30 cycles for G3PDH of denaturation 
at 95 °C for 30 s, with annealing at 60 °C for 30 s and extension at 72 °C for 1 min. 
The resulting PCR products were resolved on a 1% (w/v) agarose gel containing 10 
mg/ml ethidium bromide and photographed under UV illumination. 
Single cell calcium assay  
The [Ca2+]i was quantified in single cells with the Ca2+-sensitive fluorescent dye 
fura-2, using an InCyt Dual-Wavelength Fluorescence Imaging System (Intracellular 
Imaging, Cincinnati, OH). Briefly, rat PCNs cultured on poly-D-lysine-coated 
coverslips were incubated with 2.5 mM fura-2-acetoxymethylester at 37 °C for 30 
min in physiological salt solution (PSS) containing (mM) NaCl 138, KCl 5, CaCl2 2, 
MgCl2 1, HEPES 10, glucose 10, pH 7.4, and washed with PSS. The coverslips with 
fura-2-loaded cells were positioned on the stage of an inverted epifluorescence 
microscope (Nikon; model TMD) and stimulated with agonist at 37 °C, as described 
in the figure legends. The percentage of cells that responded to agonist was 
determined, as previously described (Kong et al., 2005). Viable cells were identified 
by responsiveness to carbachol and non-responding cells were eliminated. 
Overexpression of P2Y2 receptors in rPCNs 
Rat primary cortical neurons at DIV7 expressing very low levels of endogenous 
 65 
 
P2Y2R were transiently transfected with 1 μg of human P2Y2 receptor cDNA using 
GenCarrierTM2 (Epoch Biolabs; Sugar Land, TX), according to the manufacturer’s 
instructions. The transiently transfected cells were cultured for an additional 24-48 h 
in Neurobasal Medium with B27-AO, and used to detect sAPPα release.  
Harvesting the cells and preparation of conditioned medium  
rPCNs were plated on 6-well plates and grown until DIV7. Cells were 
serum-starved and incubated in 1 ml serum free DMEM with or without various 
compounds for specified times as indicated in the figure legends. At the end of the 
incubation period, the media were collected and centrifuged at 12,000 x g for 5 min to 
remove cellular debris. The supernatants representing conditioned media were stored 
at -80 °C for future use. To measure the level of secreted APPα, 200 μl of supernatant 
was diluted 4:1 with 50 μl of 5X Laemmli sample buffer (187.5 mM Tris-HCl, pH 6.8, 
6% (w/v) SDS, 1.8% (v/v) β-mercaptoethanol and 0.003% (w/v) bromophenol blue). 
In addition, the cells were washed twice with ice-cold PBS, and lysed in 2X Laemmli 
sample buffer (200 μl/well).  
Western blot analysis  
Samples of cell lysates and conditioned media obtained above were heated for 5 
min at 65 °C, and subjected to 7.5% (w/v) SDS-polyacrylamide gel electrophoresis 
(SDS-PAGE) and transferred to nitrocellulose membranes for protein immunoblotting. 
After overnight blocking at 4 °C with 5% (w/v) fat-free milk in TBS-T (10 mM 
Tris-HCl, pH 7.4, 120 mM NaCl, and 0.1% (v/v) Tween-20), membranes were 
incubated with either 1:1000 dilution of anti-ERK1/2, anti-phospho-ERK1/2, or 
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anti-actin antibodies for 2 h at room temperature, or 1:1000 dilution of anti-sAPPα 
overnight at 4 °C followed by incubation with HRP-conjugated anti-rabbit or 
anti-mouse IgG antibodies (1:1000 dilution in TBS-T containing 5% (w/v) fat-free 
milk) for 1 h at room temperature. Protein immunoreactivity was visualized on 
autoradiographic film using the LumiGlo Chemiluminescence System (New England 
BioLabs), according to the manufacturer’s instructions. The protein bands detected on 
X-ray film were quantified using a computer-driven scanner and Quantity One 
software (Bio-Rad, Hercules, CA). The activation levels of kinases or sAPPα release 
were expressed as a percentage of controls (i.e., total kinase or actin). 
Statistical analysis 
Results are expressed as the means ± S.E.M. of data obtained from at least 3 
experiments.  Statistical analysis of data was performed using Graph Pad Prism 
version 4.0. Statistical significance was determined by student t test between groups. 
Differences were considered statistically significant when p < 0.05 (*) and not 
significant when p > 0.05 (n.s.). 
RESULTS 
Upregulation of functional P2Y2R in rat primary cortical neurons by IL-1β 
Several subtypes of P2 nucleotide receptor mRNA are expressed in rPCNs, 
including P2Y1, P2Y4, P2Y6, P2X3, P2X5, P2X6 and P2X7 (Kong et al., 2005; 
Weisman et al., 2005). However, P2Y2R mRNA and receptor activity are barely 
detectable in these cells (Weisman et al., 2005, Kong et al., 2005, Figure 1A). Since 
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previous studies demonstrated that IL-1β causes an increase in P2Y2R mRNA 
expression in mouse primary striatal astrocytes (Stella et al., 1997), we used RT-PCR 
analysis to examine whether this cytokine could increase P2Y2R mRNA expression in 
rPCNs. After overnight incubation with 0-100 ng/ml IL-1β, P2Y2R mRNA (Figure 
1A-B), but not P2Y4R or P2Y6R mRNA (data not shown), was upregulated in an 
IL-1β dose-dependent manner. Stimulation of IL-1β-treated rPCNs with the P2Y2R 
agonist UTP caused an increase in [Ca2+]i (Figure 1C) and activation of the MAPKs 
ERK1/2 (Figure 2), indicating that functional expression of the P2Y2R is upregulated 
by IL-1β in rPCNs. Co-incubation of rPCNs with TNF-α and IL-1β did not further 
enhance the effect of IL-1β on P2Y2R-mediated calcium mobilization (data not shown) 
or ERK1/2 phosphorylation (Figures 2C-D).  
P2Y2R-mediated release of sAPPα from rPCNs treated with IL-1β  
The release of sAPPα from rPCNs was detected by immunoblot analysis of the 
cell culture media with a rabbit anti-rodent sAPPα antibody that recognizes amino 
acid residues 3-16 of Aβ and reacts well with APP (130 kDa) and all isoforms of 
sAPPα (100-120 kDa). We found that overnight treatment of rPCNs with IL-1β 
(1-100 ng/ml) caused a dose-dependent increase in sAPPα release from cells 
stimulated with 100 μM UTP (Figure 3). UTP also increased the release of sAPPα 
from rPCNs transfected with P2Y2R cDNA, as compared to untransfected rPCNs 
(Figure 4), confirming the hypothesis that UTP enhances sAPPα release from rPCNs 
through activation of the P2Y2R subtype. 
P2Y2R-mediated release of sAPPα is dependent on ADAM10/17 
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Currently, several zinc metalloproteinases have been identified as potential 
α-secretases including tumor necrosis factor alpha converting enzyme (TACE or 
ADAM17 for a disintegrin and metalloprotease 17) that catalyzes the shedding of the 
ectodomain of APP and other transmembrane proteins (Black et al., 1997; Moss et al., 
1997), and ADAM10 and MDC9 that also catalyze sAPPα production (Lammich et 
al., 1999; Koike et al., 1999). In IL-1β-treated rPCNs, UTP-induced release of sAPPα 
was significantly inhibited by TAPI-2 (Figure 5), a competitive inhibitor of 
ADAM17/TACE and ADAM10 (Kaup et al., 2002). Thus, P2Y2R-mediated APP 
processing in rPCNs is likely mediated by ADAM10/17.  
P2Y2R-mediated sAPPα release is independent of PKC 
P2Y2R activation causes the phospholipase C-dependent stimulation of PKC, and 
the activation of several other GPCRs has been reported to induce sAPPα release 
through PKC-dependent and -independent pathways (Nitsch et al., 1994 &1995; 
Checler, 1995; LeBlanc et al., 1998). Therefore, we determined whether 
P2Y2R-mediated sAPPα release is dependent on activation of PKC. Results indicated 
that the level of UTP-induced sAPPα release decreased when IL-1β-treated rPCNs 
were incubated for 30 min with GF109203 (10 μM), an inhibitor of PKC. However, 
the inhibition was not significant according to the student t test, although GF109203 
significantly inhibited 1 μM PMA-induced release of sAPPα (Figure 6). Thus, sAPPα 
release mediated by P2Y2R activation occurs independently of PKC. 
P2Y2R-mediated sAPPα release is dependent on PI3K activation 
The release of sAPPα induced by insulin requires activation of the PI3K/Akt 
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pathway (Solano et al., 2000). Since P2Y2Rs couple to PI3K activation in many cell 
types (Muscella et al., 2003; Kaczmarek et al., 2005; Wang et al., 2005), we 
determined whether PI3K/Akt regulates P2Y2R-mediated sAPPα release in 
IL-1β-treated rPCNs. Figure 7 shows that incubation of IL-1β-treated rPCNs with 10 
μM LY29004, a selective inhibitor of PI3K, prevents UTP-induced sAPPα release, 
but has no effect on constitutive release of sAPPα (Figure 7). 
Role of MAPK in P2Y2R-mediated release of sAPPα  
Previous studies in our laboratory have shown that inhibition of MAPK (i.e., 
ERK1/2) partially inhibits UTP-stimulated sAPPα release in human 1321N1 
astrocytoma cells (Camden et al., 2005). Therefore, we investigated the role of the 
MAPK pathway in UTP-stimulated sAPPα release in IL-1β-treated rPCNs. U0126, an 
inhibitor of the MAPK/ERK kinase (MEK), partially inhibited UTP-induced sAPPα 
release but not the constitutive release of sAPPα in IL-1β-treated rPCNs (Figure 8). 
These results suggest that P2Y2R-mediated sAPPα release in rPCNs is partially 
dependent on MAPK/ERK1/2 activation. 
DISCUSSION 
In the present study, we demonstrate that the pro-inflammatory cytokine IL-1β 
upregulates expression of the P2Y2R in rat primary cortical neurons (rPCNs). 
Furthermore, we report that activation of the P2Y2R in IL-1β-treated rPCNs enhances 
the release of sAPPα, a neuroprotective cleavage product of APP (Li et al., 1997; Luo 
et al., 2001; Stein et al., 2004), by stimulating α-secretase activity mediated by the 
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metalloproteinases, ADAM10/17. Inhibitor studies reveal that P2Y2R-mediated 
sAPPα release from rPCNs requires PI3K activity and is partially dependent on 
MAPK/ERK1/2 activation, but independent of PKC activation.   
Previous studies have demonstrated that P2Y2R mRNA and functional activity is 
upregulated in stressed or injured tissue, including ligated salivary gland ducts 
(Turner et al., 1998), collared carotid arteries (Seye et al., 2002), and submandibular 
gland cells from the NOD.B10 mouse model of Sjogren's syndrome (Schrader et al., 
2005). It was also reported that IL-1β induced P2Y2R mRNA expression in vascular 
smooth muscle cells (SMCs; Hou et al., 2000). IL-1 binds to a specific plasma 
membrane IL-1 type-I receptor (IL-1RI) (Sims et al., 1993), which subsequently 
associates with the IL-1 receptor-accessory protein (IL-1RAcP) to initiate intracellular 
signals (Wesche et al., 1997). Since IL-1β release has been associated with the 
pathophysiology of Alzheimer’s disease (Grammas and Ovase, 2001), we speculated 
that cytokines could upregulate P2Y2 receptor expression in neuronal cells. We found 
that endogenous P2Y2R mRNA expression and receptor activity were very low in 
untreated rPCNs but were significantly enhanced in response to IL-1β treatment 
(Figures 1 and 2; Weisman et al., 2005), suggesting that P2Y2R expression is 
regulated by transcription factors coupled to IL-1 receptor activation.  
As IL-1β-induced P2Y2R mRNA expression in vascular SMCs was dramatically 
enhanced in combination with TNF-α treatment (Hou et al., 2000), we also tested 
whether TNF-α could enhance IL-1β-induced P2Y2R expression and function. In 
rPCNs, TNF-α did not significantly enhance IL-1β-induced P2Y2R mRNA expression 
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(data not shown) or receptor activity (Figure 2D).  
Although the role of P2Y2R expression in neuronal cells is poorly understood, it 
is better established that cytokines, including IL-1β and their receptors mediate 
inflammation in Alzheimer’s brain (Brugg et al., 1995; Hauss-Wegrzyniak et al., 
1998). Therefore, we postulate that IL-1β-induced P2Y2R expression may contribute 
to inflammation.  However, other studies suggest that P2Y2R activity in human 
1321N1 astrocytoma cells can promote β-amyloid precursor protein (APP) processing 
(Camden et al., 2005) and therefore we investigated whether this pathway was 
manifested upon P2Y2R upregulation in IL-1β-treated rPCNs. APP is a 
transmembrane glycoprotein that can be detected in most tissues but is abundantly 
expressed in the brain (Anderson et al., 1989). Post-translational processing of APP 
occurs by the action of least three proteinases called α-, β- and γ-secretases (Esler and 
Wolfe, 2001). Cleavage of APP by β- and γ-secretases results in the release of several 
protein fragments, including amyloid β (Aβ), the main component in senile plaques 
found in the brains of patients with Alzheimer’s disease (Martins et al., 1991). 
Although sAPPα is constitutively released from cells, secretion of this protein is also 
regulated by neural activity and can be influenced by agonists of various receptors 
(Robert et al., 2001; Canet-Aviles et al., 2002; Camden et al., 2005). The studies 
presented here suggest that IL-1β-induced upregulation of P2Y2Rs in rPCNs (Figure 
3) or transfection of rPCNs with P2Y2R cDNA (Figure 4) significantly increases 
UTP-stimulated sAPPα release. Since sAPPα release is postulated to be 
neuroprotective in AD (Li et al., 1997; Luo et al., 2001), we suggest that P2Y2R 
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expression in neuronal cells may play neuroprotective as well as pro-inflammatory 
roles in the AD brain (Weisman et al., 2005). P2Y4 receptors are endogenously 
expressed in rat neurons and have an agonist potency order of ITP = ATP = UTP = 
ATPγS = 2-MeSATP = Ap4A (Bogdanov et al., 1998). Therefore, it is plausible to 
suggest that P2Y4Rs may contribute to the enhanced release of sAPPα evoked by 
UTP. In rPCNs without IL-1β treatment, P2Y4R mRNA is expressed at higher levels 
than P2Y2R mRNA (data not shown), and therefore the P2Y4R may mediate 
UTP-induced increases in [Ca2+]i seen in 1 out of 10 rPCNs in the absence of IL-1β 
stimulation (Figure 1C). However, in the absence of IL-1β treatment, UTP did not 
significantly increase sAPPα release from rPCNs (Figure 3), suggesting that the 
P2Y4R does not contribute to APP processing in rPCNs.  
There are three major isoforms of amyloid precursor protein (APP770, APP751 and 
APP695; Kitaguchi et al., 1988) due to alternative splicing of APP mRNA. As the 
predominant isoform in the brain (Tanaka et al., 1989), APP695 has received the most 
attention in research on Alzheimer’s disease. The ratio of APP770:APP751:APP695 
mRNA is 1:10:20 in the cerebral cortex of the brain (Tanaka et al., 1989). Compared 
with neurons, which express higher levels of APP695, astrocytes synthesize APPs of 
higher molecular weights, as expected for the Kunitz Protease Inhibitor 
(KPI)-containing isoforms, APP751 and APP770. Soluble APPα release from rPCNs 
into the medium can be detected in the form of a doublet (100-120 kDa for APP 695 
and APP 751; data not shown), indicating that multiple APP isoforms are present, 
consistent with previous reports (LeBlanc et al., 1991 & 1997; Lahiri et al., 1994; 
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Parvathy et al., 1998; Solano et al., 2000; Ma et al., 2005). 
The data presented (Figure 5) also suggest that UTP induces APP processing in 
IL-1β-treated rPCNs through activation of the metalloproteinases ADAM10/17. 
However, other members of the adamalysin family may also contribute to 
P2Y2R-mediated sAPPα release since micromolar concentrations of TAPI-2 used to 
inhibit metalloproteinase activity have been reported to inhibit members of the 
adamalysin family other than ADAM10/17 (Parkin et al., 2002).  
Sitmulation of GPCRs has been shown to regulate APP processing by 
PKC-dependent signaling pathways (Nitsch, 1992). However, APP processing can 
also be regulated by increases in [Ca2+]i, and activation of PLA2, PKA and tyrosine 
kinases (reviewed in Mills and Reiner, 1999). In human 1321N1 astrocytoma cells 
expressing human P2Y2R cDNA, UTP-induced sAPPα release is independent of 
P2Y2R-mediated activation of PKC (Camden et al., 2005). UTP-induced sAPPα 
release also occurred independently of PKC activation in IL-1β-treated rPCNs (Figure 
6). The MAPK signaling pathway has been implicated in the regulation of both 
PKC-dependent and PKC-independent APP catabolism (Mills et al., 1997; 
Desdouits-Magnen et al., 1998). PI3K also regulated α-secretase-dependent APP 
processing (Solano et al., 2000; Fu et al., 2002). It also has been reported that 
short-term interleukin-1β incubation increases the release of sAPPα via 
ERK1/2-dependent α-secretase activation in Neuroglioma U251 cells whereas PI3K 
activity is unnecessary (Ma et al., 2005). To test the involvement of ERK/PI3K in 
UTP-stimulated sAPPα release in the rPCNs, after upregulation of P2Y2Rs by 
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overnight IL-1β treatment, we incubated cells in serum free DMEM containing 
specific MEK or PI3K inhibitors followed by UTP stimulation. We found that 
inhibition of PI3K or MAPK/ERK1/2 activity in IL-1β-treated rPCNs significantly 
reduced UTP-induced sAPPα release (Figures 7 and 8). Therefore, unlike short-term 
effects of IL-1β, long-term IL-1β treatment can regulate UTP-induced sAPPα release 
in a PI3K/ERK-dependent manner, most likely involving transcriptional upregulation 
of P2Y2R. 
The results of this study strongly suggest that IL-1β evokes functional 
upregulation of the P2Y2R in rPCNs and subsequent activation of the P2Y2R 
signaling cascade by UTP results in a significant increase in sAPPα release that is at 
least partially dependent on PI3K- and ERK1/2-induced activation of the 
metalloproteinases ADAM10/17. Together, these lines of evidence suggest that under 
inflammatory conditions in the brain where IL-1β accumulates, functional P2Y2R 
expression in neuronal cells may serve a neuroprotective role in the regulation of α-, 
γ-secretase-mediated APP processing. .Since P2Y2R expression in glial cells has been 
postulated to regulate inflammatory responses that may contribute to 
neurodegeneration in AD (Weisman et al., 2005), future studies are required to 
evaluate how both neurodegenerative (i.e., glial cell-mediated inflammation) and 
neuroprotective (i.e., sAPPα release) responses coupled to P2Y2R activation are 
coordinately regulated during the progression of Alzheimer’s disease. 
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Figure 1. IL-1β upregulates functional expression of P2Y2 receptors in rPCNs. 
(A-B) Rat primary cortical neurons at DIV7 were treated for 24 h at 37 °C in 
serum-free DMEM with or without IL-1β (0 ng/ml, 1 ng/ml, 10 ng/ml, 25 ng/ml, and 
100 ng/ml) and cells were harvested for RNA isolation. The effect of IL-1β treatment 
on the expression of P2Y2R mRNA was determined by RT-PCR, as described in 
"Materials and Methods". Panel B indicates the ratio of P2Y2R to G3PDH mRNA 
levels. (C) IL-1β-treated cells were loaded with fura-2 AM for measurement of [Ca2+]i 
and positioned on the stage of an inverted epifluorescence microscope (Nikon; model 
TMD), as described in the “Materials and Methods”. Then, rPCNs were incubated in 
PSS with UTP (100 μM), and the maximum increase in [Ca2+]i was determined, as 
described in the “Materials and Methods”. Results were expressed as the percentage 
of rPCNs responding to UTP. Data represent the means ± S.E.M. of results from three 
experiments, where * represents significant differences (p < 0.05), as compared to 
rPCNs treated without IL-1β. 
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Figure 2. UTP stimulates phosphorylation of ERK1/2 in IL-1β-treated rPCNs. (A, 
C) rPCNs were deprived of serum and treated for 24 h at 37 °C in DMEM (A) with or 
without IL-1β (0 ng/ml, 1 ng/ml, 10 ng/ml, 25 ng/ml, and 100 ng/ml) or (C) with or 
without 10 ng/ml TNF-α and/or 25 ng/ml IL-1β. The next day, the media were 
removed and cells were incubated for 10 min with serum-free DMEM with or without 
100 μM UTP at 37 oC. Cell lysates were obtained and subjected to Western blot 
analysis for phosphorylated ERK1/2 and total ERK1/2, as described in "Materials and 
Methods". (B, D) UTP-induced ERK1/2 phosphorylation was expressed as the ratio of 
phosphorylated ERK1/2 to total ERK1/2 and the basal level in ERK1/2 
phosphorylation in the absence of UTP was subtracted. The increase of ERK1/2 
phosphorylation induced by IL-1β in rPCNs was expressed as the percentage increase 
over UTP-stimulated rPCNs without IL-1β-pretreatment. Data represent the means ± 
S.E.M. of results from three experiments, where “n.s.” represents no significant 
differences (p > 0.05) and where * represents significant differences (p < 0.05), as 
compared to rPCNs treated without cytokines. 
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Figure 3. Release of sAPPα is stimulated by UTP in IL-1β-treated rPCNs. (A) 
rPCNs were treated with or without IL-1β (0 ng/ml, 1 ng/ml, 10 ng/ml, 25 ng/ml, and 
100 ng/ml) for 24 h in serum free DMEM. The next day, IL-1β was removed and cells 
were incubated for 2 h in serum-free DMEM with or without 100 μM UTP or 1 μM 
PMA, a positive control. The medium was removed and assayed for sAPPα release, 
whereas actin levels were determined in cell lysates, as described in "Materials and 
Methods".  (B) UTP- and PMA-induced sAPPα release in rPCNs with or without 
IL-1β pretreatment is expressed relative to actin levels in cell lysates, after subtracting 
basal sAPPα release in the absence of agonist treatment. Data represent the means ± 
S.E.M. of results from at least three experiments, where * represents significant 
differences (p < 0.05), as compared to UTP-treated rPCNs in the absence of IL-1β 
pretreatment. 
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Figure 4. P2Y2 receptor expression in rPCNs enhances α-secretase-mediated APP 
processing induced by UTP. (A) rPCNs were transfected with human P2Y2R cDNA, 
as described in “Materials and Methods”.  Cells expressing P2Y2R mRNA (data not 
shown) were incubated for 2 h in serum-free DMEM with or without 100 μM UTP or 
1 μM PMA, and sAPPα release was determined as described in “Materials and 
Methods”, and compared to untransfected (-) controls. Actin levels in cell lysates are 
shown as a loading control.  (B) sAPPα release is expressed relative to actin levels in 
cell lysates. Data represent the means ± S.E.M. of results from three independent 
experiments, where * represents significant differences (p < 0.05) between the 
indicated sample groups. 
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Figure 5. A metalloprotease inhibitor prevents UTP-induced sAPPα release from 
rPCNs. (A) rPCNs were pretreated overnight with 25 ng/ml IL-1β and then incubated 
for 30 min with or without TAPI-2 (10 µM) followed by incubation with or without 
UTP (100 µM) for 2 h in serum-free DMEM. The release of sAPPα into the medium 
was analyzed, as described in “Materials and Methods”. (B) sAPPα release is 
expressed relative to actin levels in cell lysates. Data represent the means ± S.E.M. of 
results from six experiments, where * represents significant differences (p < 0.05) 
between the indicated sample groups.  
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Figure 6. UTP-induced sAPPα release occurs independently of PKC activation in 
IL-1β-treated rPCNs. (A) rPCNs were pretreated overnight with 25 ng/ml IL-1β and 
then incubated for 30 min with or without GF109203 (10 µM) followed by incubation 
with or without UTP (100 µM) or PMA (1 µM) for 2 h in serum-free medium. Then, 
sAPPα release into the medium was analyzed, as described in “Materials and 
Methods”. (B) sAPPα release is expressed relative to actin levels in cell lysates. Data 
represent the means ± S.E.M. of results from three experiments, where “n.s.” 
represents no significant differences (p > 0.05) and where * represents significant 
differences (p < 0.05) between the indicated sample groups. 
 87 
 
  
 
A 
 
 
B 
 
 
 
 88 
 
  
 
 
 
 
Figure 7. Inhibition of PI3K prevents UTP-induced sAPPα release in 
IL-1β-treated rPCNs. (A) rPCNs were pretreated overnight with 25 ng/ml IL-1β and 
then incubated for 30 min with or without LY29004 (1 µM) followed by incubation 
with or without UTP (100 µM) for 2 h in serum-free medium. Then, sAPPα release 
into the medium was analyzed, as described in “Materials and Methods”. (B) sAPPα 
release is expressed relative to actin levels in cell lysates. Data represent the means ± 
S.E.M. of results from three experiments, where * represents significant differences (p 
< 0.05) between the indicated sample groups. 
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Figure 8. UTP-stimulated sAPPα release in IL-1β-treated rPCNs is partially 
dependent on MAPK/ERK1/2 activation. (A) rPCNs were pretreated overnight with 
25 ng/ml IL-1β and then incubated for 30 min with or without U0126 (1 µM) 
followed by incubation with or without UTP (100 µM) for 2 h in serum-free medium. 
Then, sAPPα release into the medium was analyzed, as described in “Materials and 
Methods”. (B) sAPPα release is expressed relative to actin levels in cell lysates. Data 
represent the means ± S.E.M. of results from three experiments, where * represents 
significant differences (p < 0.05) between the indicated sample groups. 
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CHAPTER 4  
 
 
 
EXPRESSION AND REGULATION OF P2Y2 NUCLEOTIDE RECEPTORS 
IN RODENT BRAINS AND THE EFFECT OF CEREBRAL ISCHEMIA  
Unpublished data; Weisman, G.A., et al., Mol Neurobiol 31(1-3): 169-183. 
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ABSTRACT 
Large amounts of adenosine 5'-triphosphate (ATP) released from cellular sources 
under pathological conditions such as ischemia may activate purinoceptors of the P2X 
and P2Y types. Although signaling pathways for P2Y2 receptors are well understood 
in both primary glial cultures and cell lines derived from various tissues, less is 
known about P2Y2 receptor distribution in the brain. Therefore, in the present study, 
in situ hybridization and RT-PCR were utilized to examine the regional expression 
patterns of P2Y2 receptors in adult rat/mouse/gerbil brain. P2Y2R mRNA was 
expressed at relatively low levels in normal rodent brain, although expression levels 
are similar in rat, mouse and gerbil brains. In general, more abundant P2Y2R mRNA 
expression was detected in the hippocampus and cerebellum. In the hippocampus, 
P2Y2R mRNA was detected in the dentate gyrus and to a lesser extent in the CA1 and 
CA3 subregions. Transient global cerebral ischemia (i.e., 5 min occlusion of the CCA) 
did not affect P2Y2R mRNA levels in any region of gerbil brain after various 
reperfusion times (4 h, 16 h and 48 h), indicating that the P2Y2R is not regulated at 
the transcriptional level in this ischemia model. 
 
 
 
 94 
 
INTRODUCTION 
Cerebral ischemia occurs when blood supply to the brain or to regions of the 
brain is decreased due to blockage or obstruction of cerebral blood vessels. Ischemia 
can result in rapid increases in the intracellular calcium concentration and release of 
ATP from pre-synaptic neurons followed by ATP depletion that can lead to neuronal 
cell death (Golstein and Kroeme, 2006).  
ATP release can activate two types of purinergic receptors: ligand-gated ion 
channel P2X receptors and G protein-coupled P2Y receptors (Burnstock, 1980). 
Among the known P2 receptor subtypes, P2Y2 and P2X7 nucleotide receptors have 
gained recent attention due to their widespread distribution in neuronal cells and their 
roles in the regulation of cell proliferation, inflammation, and apoptosis (reviewed in 
Franke et al., 2006). 
Recent studies showed that brain astrocytes express P2Y2 receptors and that 
P2Y2R expression, as opposed to P2Y1R, is upregulated in freshly isolated astrocytes 
in hippocampus during development (Zhu and Kimelberg, 2001). Upregulation of 
P2Y2Rs also has been shown to occur in many other cell types, tissues and injury 
models as previously described (Chapter 3; Turner et al., 1997; Erlinge et al., 1998; 
Hou et al., 1999; Seye et al., 1997 & 2002; Shen et al., 2004; Schrader et al., 2005). 
Here, in situ hybridization and RT-PCR were utilized to examine the regional 
expression patterns of P2Y2 receptor subtypes in adult rodent brain and a gerbil 
transient ischemia model was used to study the regulation of P2Y2R mRNA 
expression in response to brain ischemia.  
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MATERIALS AND METHODS 
Materials  
The RNeasy Mini Kit was obtained from Qiagen (Chatsworth, CA, USA). The 
cDNA Synthesis Kit and the PCR Kit were obtained from Invitrogen Life Technology 
(Carlsbad, California, USA). The Lig'nScribe Reaction Kit was from Ambion (Austin, 
TX, USA). The [35S]-NTP RNA Labeling Kit (SP6/T7) was from Roche (Indianapolis, 
IN, USA). [35S]-UTP and [35S]-dATP were obtained from NEN (Boston, MA). All 
other biochemicals were obtained from Sigma Chemical Co. (St. Louis, MO, USA).
RNA extraction and RT-PCR 
Different regions (i.e., hippocampus, cerebellum, cerebral cortex, brain stem and 
the rest of the brain) were dissected from adult rodent brain. Total RNA was extracted 
from tissues in four steps: a. tissue was reduced from pieces (10-100 mg) to a powder 
with a mortar and pestle unit containing liquid nitrogen; b. powdered tissue was 
dissolved in 1 ml Trizol reagent and large pieces of undissolved tissue were removed; 
c. 200 μl of chloroform was added to the samples, which were vortexed vigorously 
and centrifuged for 15 min at 12,000 x g at 4 °C; and d. the upper aqueous phase was 
collected and one volume of 70% (v/v) ethanol was added, mixed and RNA was 
purified using the Qiagen Rneasy Mini Kit (Qiagen). 
cDNA was synthesized by reverse transcription using purified RNA from mouse 
tissues (Invitrogen Life Technology). A P2Y2 receptor cDNA fragment was amplified 
from the mouse cDNA by PCR using a 35 cycle program (94 °C for 1 min, 60 °C of 
the annealing temperature for 30 sec, 72 °C for 1 min; G3PDH was used as a control. 
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with 30 cycles and 55 °C for annealing) in the presence of 50 U/ml Taq polymerase 
(ThermoAceTM DNA polymerase from Invitrogen) and two P2Y2R C-terminal primers 
(1 μmol/l): gerbil P2Y2 forward: 5’-TGC TGC CCC TGT CCT ACG GCG TGG-3’ 
(1-24 of AF313448; the sequence of gerbil P2Y2R from   
http://www.ncbi.nlm.nih.gov/entrez/viewer.fcgi?db=nuccore&id=12751144), gerbil 
P2Y2 reverse: 5’-AGG TTG GTG TAG AAG AGG AAG CGC-3’ (241-218 of 
AF313448). The following primers for human G3PDH were used as a control: sense 
5'-TGA AGG TCG GAG TCA ACG GAT TTG GT-3', antisense 5'-CAT GTG GGC 
CAT GAG GTC CAC CAC-3'. PCR products were resolved by 2% agarose gel 
electrophoresis, and P2Y2/G3PDH ratios were determined by densitometry. 
Gerbil global cerebral ischemia model 
Adult male Mongolian gerbils (60–80 g body weight) (Charles River, 
Wilmington, MA) were given free access to water and lab chow and maintained at 
22 ± 2 °C with a constant humidity under a 12:12 h light:dark cycle. Gerbils were 
randomly divided into a sham control group, an ischemic group and an ischemic 
group with resveratrol. For some animals in each group, resveratrol (Sigma, St. 
Louis, MO) was dissolved in corn oil and injected intraperitoneally (30 mg/kg body 
weight) immediately after and 24 h after induction of ischemia by occlusion of both 
common carotid arteries (CCAs), as previously described (Wang et al., 2002). Sham 
controls also were injected with the same volume of corn oil and underwent similar 
surgical procedures without occlusion of the CCAs. The animal protocol was 
approved by the University of Missouri-Columbia Animal Care and Use Committee 
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(Protocol #1741). Experiments were in accordance with the NIH Guidelines for the 
Care and Use of Laboratory Animals. To eliminate gerbils that have communicating 
arteries, regional cerebral blood flow (rCBF) was monitored before and after 
clamping the bilateral CCA using a laser Doppler flowmeter (MBF3D, Moor 
Instruments, Devon, UK). Gerbils showing a decrease in rCBF of less than 80% 
upon occlusion of CCAs were excluded from subsequent analyses (Wang et al., 
2002). 
Tissue sections  
Normal/sham/ischemic rodent brains were removed, wrapped in parafilm and 
aluminum foil and placed in tightly capped 50 ml conical tubes, unless the brains 
were sectioned immediately. Stored tissue was cut into 12 µm-thick sections, 
thaw-mounted onto microscope slides, dried briefly on a warm plate (32 °C; 1 min), 
and kept in 100-place slide boxes at -80°C until in situ hybridization.  
Probes 
To generate P2Y2R specific riboprobes for in situ hybridization, a T7 promoter 
adapter was ligated to the 247-bp P2Y2R fragment amplified by reverse 
transcription-polymerase chain reaction (RT-PCR) with the Lig'nScribe Reaction Kit 
(Ambion). Antisense and sense riboprobes were obtained by in vitro transcription with 
[35S]-UTP using the [35S]-NTP RNA Labeling Kit (SP6/T7) (Roche). P2Y2R 
oligoprobes were prepared by labeling the following oligonucleotides with [35S]-dATP 
at the free 3’ hydroxyl end using terminal deoxynucleotidyl transferase: 1. 5’-GAT 
GGC GTT GAG GGT GTG GCA ACT GAG GTC AAG TGA TCG GAA GGA-3’; 
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and 2. 5’-CGT TCC AGG TCT TGA GGC GGC ACA GGA AGA TGT AGA)-3’. 
In situ hybridization 
Hybridization was performed overnight at 55 °C for the riboprobes and 37 °C for 
the oligoprobes in a humidified chamber, as described previously (Simonyi et al., 
2002). Briefly, normal rodent brain or ischemic hippocampal sections were fixed in 
situ by 4% (v/v) paraformaldehyde for 5 min, then rinsed with 2 × SSC. Next, 
sections were dehydrated and delipidated with the following graded series of ethanol 
(EtOH) dilutions and chloroform: 1 min in 50% EtOH, 1 min in 70% EtOH, 1 min in 
80% EtOH, 2 min in 95% EtOH, 1 min in 100% EtOH, 5 min in Chloroform, 1 min in 
100% EtOH, and 1 min in 95% EtOH. The sections then were air-dried. Sections to be 
used as negative controls were treated with RNase A solution (10 mg RNase/50 ml, 
0.5 M NaCl, 0.01 M Tris, 0.001 M EDTA, pH = 8) at 37 °C for 30 min, then washed 
in 1 X SSC three times for 1 min each, dehydrated twice with 70% EtOH for 2 min, 
twice with 80% EtOH for 2 min, and twice with 90% EtOH for 2 min. Next, sections 
on slides were hybridized under coverslips in a humidified chamber at 55 °C 
overnight in 25 μl hybridization buffer containing approximately 1-2 × 106 dpm 
radioactive probe (antisense or sense) and 1 μl nonradioactive probe. After sections 
were cooled to room temperature, coverslips were removed in 4 × SSC, washed 4 
times in 4 × SSC for 15 min each at room temperature, and incubated in RNase buffer 
for 30 min at 37 °C to reduce nonspecific background. Then, sections were washed, 
dehydrated, and exposed to a radiosensitive film (Kodak Biomax MR-1). 
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Image analysis and data analysis 
Using standard autoradiographic techniques, the sections on slides were apposed 
to radiosensitive film (Kodak Biomax MR-1) with [14C]-labeled calibration standards 
(American Radiolabeled Chemicals, St. Louis, MO) for 1 week and then developed. 
The standards comprised of 16 [14C]-labeled standards on glass slides with 0.002 to 
3.58 µCi/g radioactivity were used to construct linear calibration curves of 
tissue-equivalent radioactivity (µCi/g) relative to the film optical density. Based on 
the standard curve, microdensitometry of film autoradiograms was performed on the 
signal over different hippocampal subregions using the BIOQUANT True Color 
Windows 95 software version 2.50, as previously described (Shelat et al., 2006). The 
amount of [35S]-labeled probe radioactivity (µCi/g) within various hippocampal 
subregions was quantitated, from which background radioactivity/optical density was 
subtracted. The average density measured from various hippocampal subregions fell 
within the linear range of the standards.  
Data are expressed as means ± S.E.M.  The number of animals in each group 
varied between 15 and 23 except for the resveratrol-treated groups which contained 7 
animals. Statistical differences between sample groups were evaluated by ANOVA 
and Student-Newman-Keuls test, where p < 0.05 was considered to be significant..  
RESULTS 
P2Y2R mRNA expression in rodent brains 
P2Y2 receptor riboprobes were designed from a cloned 247 base pair sequence of 
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gerbil P2Y2R cDNA that has high similarity to the rat gene sequence. Two 
oligoprobes complementary to different regions of the cDNA were prepared. These 
probes and the antisense riboprobe produced identical patterns of hybridization when 
tested on adjacent sections (data not shown). Sense riboprobe and RNase treatment 
were used as two negative controls for nonspecific binding. Both the RNase-treated 
tissue labeled with oligoprobes (or antisense probe) and the untreated ischemic tissue 
labeled with sense riboprobe had clean backgrounds, which indicated weak 
nonspecific binding. P2Y2 receptor mRNA was expressed at relatively low levels in 
various brain regions, but was most abundant in hippocampus and cerebellum in rat, 
mouse and gerbil brains (Figure 1). Similar P2Y2R expression patterns in adult rat 
brains were demonstrated by RT-PCR (Figure 2A). P2X7 receptor mRNA was 
detected in all brain regions (i.e., cerebral cortex, cerebellum, brain stem, 
hippocampus and the rest of the brain), but expression was highest in hippocampus, 
cerebellum and cortex (Figure 2B). Other P2Y receptor mRNAs were expressed in rat 
hippocampus (P2Y1) and cortex (P2Y1 and low levels of P2Y6) (Figure 2C). 
P2Y2 mRNA expression in the gerbil hippocampus after transient ischemia  
Transient ischemia induced by a 5-minute occlusion of CCAs in the gerbil causes 
selective and delayed neuronal death (DND) of CA1 pyramidal neurons associated 
with activation of surrounding astrocytes in the hippocampus (Kirino, 1982). 
Regulation of P2Y2R mRNA expression in response to ischemia was studied in 
hippocampal subregions of gerbil brain after a 5 min CCA occlusion followed by 
various reperfusion times (Figure 3). In control hippocampus, the hybridization signal 
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was relatively high in dentate gyrus as compared to the CA1 and CA3 regions (Figure 
4).  
Since increased expression of P2Y2 receptors has been associated with 
inflammation, tissue damage and disease (Weisman et al., 2005; Seye et al., 2006), 
P2Y2 mRNA expression was quantified in gerbil hippocampus after ischemic insult/ 
reperfusion. Statistical analysis showed that there was no significant change of P2Y2 
mRNA expression in the CA1 region during early stages of transient ischemic injury 
(5 min occlusion + 4 h/16 h/48 h reperfusion; Figure 3 A-C). P2Y2 receptor mRNA 
levels were not significantly changed in other hippocampal subregions in response to 
CCA occlusion followed by 4-48 h reperfusion (Figure 4). Neurons in the 
hippocampal CA1 region were depleted 3 days after occlusion/reperfusion, whereas 
microglia and astrocytes proliferated in this brain region. Although P2Y2R mRNA 
was hard to detect in the CA1 region (Figure 3D), results appear to indicate that 
P2Y2R mRNA expression is not transcriptionally regulated by ischemia in this animal 
model.  
Resveratrol administration does not affect P2Y2R mRNA levels in normal or ischemic 
gerbil brain  
Increased oxidative stress has been implicated in the mechanisms of DND 
following cerebral ischemic insult (Kirino, 2000). As a polyphenolic compound 
enriched in grape and red wine, resveratrol has drawn wide attention lately as an 
effective anti-oxidative agent (Ray et al., 1999; Hung et al., 2000; Huang et al., 2001; 
Giovannini et al., 2001; Fremont, 2003). Resveratrol has been shown to protect 
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against global cerebral ischemic injury in gerbils (Wang et al., 2002) and 
neurotoxicity induced by kainic acid (Wang et al., 2004). Therefore, we tested 
whether resveratrol, a polyphenolic antioxidant enriched in grape, has an effect on the 
P2Y2R mRNA expression and/or promote neuroprotective signaling through 
activation of P2Y2R in gerbil ischemic brain. Mongolian gerbils were divided into 
three groups: a sham control group, an ischemic group and ischemic group treated 
with resveratrol. Results indicated that injection of resveratrol significantly prevented 
DND (data not shown), but had no effect on the P2Y2R mRNA expression levels in 
ischemic animals (Figure 5). 
DISCUSSION 
This study demonstrated similar expression patterns for P2Y2 receptor mRNA in 
the brains of adult rats, mice and gerbils. P2Y2 receptor mRNA was expressed at 
relatively low levels in various brain regions, but was most abundant in hippocampus 
and cerebellum. P2X7 receptor mRNA was detected in all brain regions, but was 
expressed at highest levels in hippocampus, cerebellum and cortex. 
Rapid release of ATP from pre-synaptic vesicles in the early stages of ischemic 
injury can activate P2 nucleotide receptors and is likely to be an important signal in 
the ischemic process (Franke and Illes, 2006b). The P2Y2 receptor subtype can 
mediate cellular responses typically associated with cell proliferation and 
inflammation that may contribute to ischemic responses in cells (Erb et al., 2006). 
Moreover, upregulation of the P2Y2R subtype has been found in cells and tissue 
sexposed to stress and injury (Koshiba et al., 1997; Turner et al., 1997 and Seye et al., 
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2002). Thus, it is important to investigate how P2Y2Rs are regulated in neuronal cells 
in response to brain ischemia.  
Extensive evidence demonstrates that ischemia and reperfusion causes the 
upregulation of P2X (P2X2, 4, 7) and P2Y (P2Y1) receptor subtypes in neurons and 
glial cells in specific brain regions (Franke and Illes, 2006b) and suggests a direct role 
for these receptors in the pathophysiology of cerebral ischemia in vitro and in vivo 
(Cavaliere et al., 2002, 2003, 2004; Franke et al., 2004a). In contrast, the present 
studies show that P2Y2 receptor mRNA expression is not significantly altered in 
gerbil brain hippocampus at different ischemic stages (i.e., 4-48 h of reperfusion after 
a 5 min CCA occlusion).  
Resveratrol is a polyphenolic antioxidant enriched in grapes and red wine that has 
been found to reduce ischemia/reperfusion injury in both non-neural organs such as 
rat hearts and kidney (Ray et al., 1999; Hung et al., 2000; Giovannini et al., 2001) and 
in the rat focal cerebral ischemia and gerbil transient global cerebral ischemia models 
(Huang et al., 2001; Wang et al., 2002). The present studies indicate that resveratrol 
injection did not alter P2Y2R mRNA levels in ischemic gerbil brain. Therefore, 
resveratrol mediates neuroprotective signaling independent of the transcriptional 
activation of P2Y2R in gerbil ischemic brain, although further studies are warranted to 
examine the mechanisms underlying transcriptional regulation of P2Y2R expression 
and the effect of antioxidants.  
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Figure 1. P2Y2 receptor mRNA expression in the adult rodent brain. The 
expression pattern of P2Y2 nucleotide receptor mRNA in gerbil/rat/mouse brains was 
identified by in situ hybridization with a [35S]-labeled riboprobe, as described in 
“Materials and Methods”. Rnase A-treated sections were used as a negative control. 
HI, hippocampus; CE, cerebellum; CO, cerebral cortex.  
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Figure 2. Expression of mRNA for P2Y2, P2X7, P2Y1, P2Y4 and P2Y6 nucleotide 
receptors in adult rat brain. (A) P2Y2, (B) P2X7, and (C) P2Y1, P2Y4 and P2Y6 
receptor mRNA expression levels in different regions of adult rat brain were analyzed 
by RT-PCR. Total RNA was prepared from hippocampus (HI), cerebral cortex (CT), 
cerebellum, brain stem and the rest of the male Sprague-Dawley rat brain. Human 
1321N1 astrocytoma cells expressing specific rat P2Y receptor subtypes were used as 
a positive control for each PCR reaction. Expression levels of the housekeeping gene 
G3PDH were measured as a control. RT-PCR was performed in the presence (+) or 
absence (-) of reverse transcriptase.
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Figure 3. P2Y2R mRNA levels in the gerbil hippocampal CA1 region after 
ischemic injury.  P2Y2R mRNA expression in the gerbil hippocampal CA1 region 
was quantified at different stages of transient cerebral ischemia/reperfusion, as 
described in “Materials and Methods”. (A) 5 min occlusion + 4 h reperfusion; (B) 5 
min occlusion + 16 h reperfusion; and (C) 5 min occlusion + 48 h reperfusion; and (D) 
gerbil hippocampal sections are shown after a 5 min CCA occlusion + 4-72 h 
reperfusion.  
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Figure 4. Expression of P2Y2R mRNA in hippocampal subregions after global 
cerebral ischemia. P2Y2R mRNA levels were quantified in different hippocampal 
regions of sham-operated gerbils (control) and gerbils after a 5 min CCA occlusion 
followed by a 16 h reperfusion. CA3: hippocampal CA3 subregion; hilus: also called 
CA4 but considered part of the dentate gyrus; DG: dentate gyrus, which contains 
upper blade part, lower blade part and the hilus. 
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Figure 5. Effect of resveratrol on P2Y2R mRNA expression in the CA1 region of 
gerbil brain after transient global cerebral ischemia. Mongolian gerbils were 
administered resveratrol by injection (Resv; 30 mg/kg body weight) immediately after 
and 24 h after a 5 min CCA occlusion followed by reperfusion (ischemia). A 
sham-operated group served as a control. Injection of resveratrol did not significantly 
affect P2Y2 receptor mRNA levels in the CA1 region under ischemic conditions (n = 
7 animals).  
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 CHAPTER 5   
GENERAL DISCUSSION 
ATP and other extracellular nucleotides are released from a variety of cell types 
in the central nervous system including neurons, glia, endothelium, and blood cells 
(Bergfeld et al., 1992; Ciccarelli et al., 1999; Ahmed et al., 2000; Ostrom et al., 2001). 
Nucleotides have been suggested to act as a neuroprotective growth factor by 
regulating cell differentiation, proliferation, and survival, as well as a neurotoxic 
signal in promoting neuronal degeneration and cell death (Franke and Illes, 2006). 
Extracellular nucleotides activate two classes of P2 nucleotide receptors (P2X1-7 
ligand-gated ion channels and P2Y1,2,4,6,11-14 G protein-coupled receptors; Sak and 
Webb, 2002; Inbe et al., 2004). P2X/Y receptor families are widely distributed and 
developmentally expressed in the central nervous system (CNS), as previously 
described (reviewed in Franke and Illes, 2006b), which suggests a role for purinergic 
signaling in the development of brain structures. Further studies show that P2 
nucleotide receptors play important physiological and pathophysiological roles in a 
variety of biological processes including neuronal growth, survival and brain injury 
(Franke et al, 2006a & b).  
The upregulation of P2 nucleotide receptor expression has been reported after 
ATP/NGF/cytokine stimulation (Rathbone et al., 1999; D’Ambrosi et al., 2001), and 
in tissue injury and disease models of the CNS and other tissues (Collo et al., 1997; 
Moore et al., 2000; Seye et al., 2002; Cavaliere et al., 2003 &2004; Parvathenani et 
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al., 2003; Franke et al., 2004). In Alzheimer’s disease and brain ischemia, in vivo and 
in vitro studies have shown that P2X2 (in ischemia), P2X4 (in ischemia), P2X7 (in 
ischemia and AD) and P2Y1 (in AD) receptor expression is upregulated in specific 
cell types, as described in Table 1.  
The P2Y2R can be equipotently activated by ATP and UTP to stimulate G 
protein-coupled signaling pathways, and to transactivate growth factor receptors (Liu 
et al., 2004) and integrins, e.g., αVβ3/β5 (Erb et al., 2001; Wang et al., 2005; Liao et 
al., 2007). Studies also indicate that upregulation of the P2Y2R occurs in a variety of 
cell and tissue types after injury (Seye et al., 2002; Schrader et al., 2005; Kunzli et al., 
2007). The P2X7R is distinguished from other P2XR subtypes due to its inability to 
form heteromeric channels, the presence of an extended C-terminal tail; the high 
concentrations of agonist required for activation, and the ability to form pores that 
enable the passage of large molecular weight molecules (Sperlagh et al., 2006). 
P2X7R functions in the CNS include the regulation of synaptic transmission and 
neuronal cell death (Sperlagh et al., 2006).  
This dissertation describes the functional expression and regulation of P2Y2 
receptor activity by IL-1β in primary neurons and the upregulation of the P2Y2R in 
tissue injury models.  Results obtained demonstrate that P2Y2Rs mediate the release 
of neuroprotective sAPPα, whereas P2X7Rs mediate apoptosis in rat primary cortical 
neurons. However, further studies are needed to better understand the roles of P2Y2 
and P2X7 nucleotide receptors in neurodegeneration, such as the mechanism whereby 
IL-1β induces upregulation of P2Y2R expression, the role of P2Y2Rs in APP 
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translocation/phosphorylation and Aβ production induced by caspase-dependent APP 
processing, and the relationship of P2X7R-mediated neuronal apoptosis to the AD 
phenotype.  
Major contributions and significance 
The scientific significance of this dissertation work to the field is summarized 
below.  
1) P2Y2 receptor expression was identified: a) in rat primary cortical neurons 
(Kong et al., 2005 & manuscript in preparation); b) in adult rodent brains; and c) in 
brain hippocampus at different stages of cerebral ischemia (unpublished data; 
Weisman et al., 2005; Chapter 4).  2) Upregulation of the P2Y2R occurs after 
IL-1β treatment in rPCNs and after collar placement around rabbit carotid 
arteries. In rat primary cortical neurons, IL-1β treatment increased P2Y2R mRNA 
expression and receptor activity in a dose-dependent manner (Kong et al., manuscript 
in preparation; Chapter 3). Other studies demonstrate the upregulation of P2Y2Rs in 
endothelial and smooth muscle cells of collared rabbit carotid arteries (Appendix-1; 
Seye et al., 2002 & 2003; reviewed in Seye et al., 2005). 3) P2Y2R activation 
enhances α-secretase-dependent amyloid precursor protein processing in rPCNs. 
Previous studies from our lab with the human 1321N1 astrocytoma cell line that does 
not express endogenous P2Y2Rs, indicated that transfection with human P2Y2R 
cDNA enables UTP to induce α-secretase-dependent APP processing (Camden et al., 
2005). The current studies (Chapter 3) confirmed that P2Y2Rs upregulated by IL-1β 
treatment of primary cultures of rat cortical neurons mediate neuroprotective APP 
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processing, and suggest that P2Y2R expression in neurons could be targeted to 
suppress neurodegenerative Aβ deposition in Alzheimer’s disease (Kong et al., 
manuscript in preparation). 4) P2X7Rs mediate apoptosis of rPCNs. In rat PCNs, 
functional expression of P2X7Rs was detected and activation of the P2X7R was found 
to mediate caspase-dependent apoptosis and studies presented identified the signaling 
pathways involved (Kong et al., 2005; Chapter 2). 5) P2Y2Rs mediate UTP-induced 
intimal hyperplasia in collared rabbit carotid arteries. Our studies demonstrate for 
the first time that functional P2Y2R upregulation leads to the development of 
neointimal hyperplasia in collared rabbit carotid arteries, a response associated with 
atherosclerosis and restenosis after angioplasty (Seye et al., 2002; Appendix-1). 
Further studies showed that the P2Y2 receptor also mediates UTP-induced vascular 
cell adhesion molecule-1 expression in coronary artery endothelial cells that promotes 
the binding of monocytes leading to vascular inflammation (Seye et al., 2003). 6) 
Studies in collaboration with other lab members identified P2Y2 receptor 
signaling pathways involving integrin interactions and demonstrated that 
antagonists of CD39 ectonucleotide triphosphate diphosphohydrolase 
(E-NTPDase) activity also inhibit P2Y2R functions (Erb et al., 2001; Gendron et al., 
2002; Wang et al., 2005). Studies with the E-NTPDase inhibitor BG0136 showed that 
this compound displays inhibitory activity towards the P2Y2R expressed in human 
1321N1 cells, which suggests that BG0136 may represent a novel P2 nucleotide 
receptor antagonist (Gendron et al., 2002; Appendix-2). Other studies demonstrate 
that the P2Y2 nucleotide receptor interacts with αV integrins through an RGD domain 
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in the first extracellular loop of the P2Y2R. These P2Y2R/αv integrin interactions were 
shown to be required for Go-mediated signal transduction that regulates astrocyte 
migration (Erb et al., 2001; Appendix-3). 
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A-1. FUNCTIONAL P2Y2 NUCLEOTIDE RECEPTORS MEDIATE URIDINE 
5’-TRIPHOSPHATE-INDUCED INTIMAL HYPERPLASIA IN COLLARED 
RABBIT CAROTID ARTERIES 
Seye et al., (2002) Circulation 106(21):2720-2726. 
 
ABSTRACT 
Extracellular UTP induces mitogenic activation of smooth muscle cells (SMCs) 
through binding to P2Y2 nucleotide receptors. Previous reports also show that P2Y2 
receptor mRNA is upregulated in intimal lesions of rat aorta, but it is unclear how 
P2Y2 receptors contribute to development of intimal hyperplasia. In the present 
studies, we used a silicone collar placed around rabbit carotid arteries to induce 
vascular injury and intimal thickening. Collar placement caused rapid upregulation of 
P2Y2 receptor mRNA and receptor activity (i.e., UTP-induced increases in the 
intracellular calcium concentration) in medial SMCs before appearance of neointima. 
Neointimal development was significantly enhanced by perivascular infusion of UTP 
(100 µmol/L) and neointima were infiltrated by macrophages. UTP also stimulated 
osteopontin expression in situ in collared arteries and in cultured SMCs in a 
dose-dependent manner. Furthermore, P2Y2 antisense oligonucleotide inhibited 
osteopontin expression induced by UTP suggesting that this response to UTP was 
specifically mediated by P2Y2 receptor subtype. In conclusion, these findings indicate 
for the first time a role for the UTP/ATP receptor, P2Y2, in development of intimal 
hyperplasia associated with atherosclerosis and restenosis. 
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 INTRODUCTION 
Atherosclerosis is an immunoinflammatory process that involves complex 
interactions between the vessel wall and blood components primarily affecting the 
large conduit arteries. Endothelial dysfunction is thought to be a key factor in the 
development of vascular disease (Ross 1993; Ferns et al., 1991; Wang et al., 1992). 
Previous studies suggest that an intact endothelium is important in maintaining a low 
proliferative state of smooth muscle cells (SMCs) under normal conditions (Gordon, 
1986). In arterial injury, nucleotides are released from endothelial cells, SMCs, and 
various blood cells and can bind to P2 receptors to modulate proliferation and 
migration of SMCs, which is known to be involved in intimal hyperplasia that 
accompanies atherosclerosis and postangioplasty restenosis (Erlinge et al., 1993). The 
aim of this study was to determine whether activation of the P2Y2R promotes intimal 
hyperplasia under conditions that maintain the vascular endothelium. 
MATERIALS AND METHODS 
Cell culture 
Rabbit SMCs obtained from normal carotid arteries by enzymatic dissociation 
were maintained in culture and used from passages 4 to 6. 
Phosphorothioate-modified oligonucleotides to rabbit P2Y2R were synthesized and 
purified by Integrated DNA Technologies (ADT). Sequences including translation 
initiation site were as follows: sense 5'-GGGCAATGGCACTCTTCCCTCACCTG 
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ACA-3',     antisense 5'-TGTCAGGTGAGGGAAGAGTGCCATTGCCC-3'. 
Sequences were checked for uniqueness with the National Center for Biotechnology 
Information’s Basic Local Alignment Search Tool (BLAST). SMCs were incubated 
with 0.1 or 1 µmol/L P2Y2R sense or antisense S-oligonucleotides for 6 h in 
serum-free medium containing 1.4% DOTAP liposomal reagent (Roche 
Diagnostics). Serum-free medium was added, and cells were cultured for an 
additional 20 h. FITC-conjugated P2Y2R antisense and sense oligonucleotides were 
used to quantify cellular oligonucleotide uptake by SMCs. Cells were rendered 
quiescent by a 24 h incubation in serum-free medium before stimulation with 
nucleotides. 
Collar implantation 
The collared rabbit carotid artery model was employed to induce arterial stress 
(Figure 1). Protocols conformed to Animal Care and Use guidelines of the 
University of Missouri-Columbia. New Zealand White rabbits (42 animals) were 
anesthetized subcutaneously with ketamine (33 mg/kg body weight) and xylazine (7 
mg/kg body weight). Rabbits were maintained under respiration with oxygen and 
0.2% isoflurane. A nonocclusive, biologically inert, flexible silicone collar (20 mm 
long; inlet/outlet diameter 1.8 mm; Silicone MED-4211, Nusil Technology) was 
placed around a carotid artery (Figure 1), and the contralateral artery was sham 
operated, i.e., isolated from surrounding connective tissue and exposed to similar 
stretch. Arteries were collected at day 3 (n = 12), 7 (n = 14), or 14 (n = 14). Two 
collars per animal were implanted in another series of experiments, and each was 
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connected to an osmotic minipump (Alzet 2 ML2; Alza Corporation) implanted 
subdermally in the thoracic region. The pump continuously delivered (5 µl/h) UTP 
(100 µmol/l) or PBS (mmol/l: NaCl 154, Na2HPO4 8, NaH2PO4 2, EDTA 0.2) for 3 
(n = 14), 7 (n = 14), and 14 (n = 14) days. After surgery, analgesic (Buprenex; 0.1 to 
0.5 mg/kg body weight) was administered. 
Immunoblotting 
Cultured cells were solublized in 2X Laemmli sample buffer (120 mmol/L 
Tris-HCl, pH 6.8, 2% SDS, 10% sucrose, 1 mmol/L EDTA, 50 mmol/L 
dithiothreitol, 0.003% bromophenol blue). Rabbit aortas were homogenized with a 
polytron homogenizer in buffer containing 0.9% NaCl, 20 mmol/L Tris-HCl, pH 7.6, 
1 mmol/L PMSF in 0.2% Triton X-100. Equivalent amounts of protein (100 µg) 
were subjected to 10% SDS-PAGE and transferred to nitrocellulose membranes for 
immunoblotting. Detection of OPN (Chemicon International) was performed with 
rat anti-human OPN (1:1000 dilution) and horseradish-peroxidase-conjugated goat 
anti-rat IgG (1:1500 dilution) as primary and secondary antibodies, respectively. For 
signal normalization, membranes were reprobed with anti-mouse -tubulin antibody 
(1:1000 dilution; Santa Cruz Biotechnology).  
RESULTS 
Effect of local UTP application on OPN expression 
Immunoblots of sham-operated arteries indicated lack of OPN expression (Figure 
2A, Lane 5), whereas collared arteries at day 14 expressed OPN (Figure 2A, Lane 2). 
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Local UTP infusion greatly increased OPN expression (Figure 4A, Lane 4) compared 
with PBS (Figure 2A, Lane 3).  
UTP-induced OPN expression is mediated by P2Y2Rs in SMCs 
UTP exposure for 8 h stimulated OPN expression in vascular SMCs (Figure 2B) in 
a dose-dependent manner (Figure 2C). ATP and 10% FBS (positive control) induced 
OPN expression, whereas ADP, 2-MeSATP, and UDP did not (Figure 2B), which 
suggests that P2Y2Rs mediate OPN expression. To conclusively demonstrate the role 
of P2Y2Rs, SMCs incubated with 0.1 or 1 µg of P2Y2R antisense or sense 
oligonucleotides were stimulated with 50 µmol/L UTP for 8 h. Antisense (Figure 2D, 
Lanes 5 and 6) but not sense (Figure 2D, Lanes 2 and 3) P2Y2R oligonucleotides 
inhibited UTP-induced OPN expression in SMCs. 
DISCUSSION 
Proliferation of SMCs is a hallmark of vascular diseases such as atherosclerosis 
and restenosis following angioplasty (Hanke et al., 1990). Nucleotides released from 
various arterial and blood cells (Di Virgilio and Solini, 2002) can bind to P2 
nucleotide receptors. In our present studies, in vivo experiments showed that the P2Y2 
receptor was functionally upregulated in both SMCs and endothelial cells after collar 
implantation (Seye et al., 2002). Moreover, intimal thickening of collared rabbit 
carotid arteries was greatly enhanced by in situ UTP application (Seye et al., 2002) 
and was closely associated with osteopontin (OPN) expression in medial SMCs 
(Figure 2A). In vitro studies showed that both UTP and ATP increased OPN 
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expression in cultured SMCs whereas ADP, UDP, and 2-MeSATP were ineffective 
(Figures 2B-C), which suggests a role for the P2Y2R in which ATP and UTP are 
equipotent, and is confirmed by the inhibition of UTP-induced OPN expression in 
cultured SMCs after P2Y2R antisense oligonucleotide treatment (Figure 2D). 
Extracellular nucleotides may also cause cell recruitment by inducing lymphocyte 
and macrophage adhesion to human pulmonary artery endothelial cells, as 
demonstrated in vitro (Parker et al., 1996). In collared rabbit carotid arteries, we 
found that local UTP delivery via an osmotic pump induced intimal accumulation of 
macrophages mediated by P2Y2 receptors (data not shown; Seye et al., 2002).  
In conclusion, these studies demonstrate for the first time that extracellular UTP 
and the P2Y2R contribute to the development of arterial lesions associated with 
atherosclerosis and restenosis. 
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Figure 1. Collared rabbit carotid artery model. New Zealand White rabbits (42 
animals) were anesthetized and (A) a nonocclusive, biologically inert, flexible 
silicone collar (20 mm long; inlet/outlet diameter 1.8 mm; Silicone MED-4211, 
Nusil Technology) was (B) placed around a carotid artery, and the contralateral 
artery was sham operated, i.e., isolated from surrounding connective tissue and 
exposed to similar stretch. 
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Figure 2. Nucleotide-induced OPN expression in collared carotid arteries and 
SMC cultures. A. Collared arteries connected to an osmotic minipump were 
continuously infused with UTP or saline for 14 days. Lane 1, control (kidney); 2, 
collar without infusion; 3, collar with PBS, 4, collar with UTP; 5, sham-operated 
artery. Blots were reprobed with anti- -tubulin antibody. B-C. SMCs were stimulated 
with 10% FBS or (B) 50 µmol/L nucleotide or (C) the indicated UTP concentration. 
Immunoblot analysis was performed with anti-OPN antibodies. Data represent 3 (A) 
or 5 (B) experiments. D. SMCs incubated with P2Y2R sense or antisense 
S-oligonucleotides for 6 h in DMEM containing 1.4% DOTAP liposomal reagent 
were cultured for an additional 16 h in serum-free medium before 50 µM UTP 
treatment. Cells were incubated with serum-free medium (Lane 1); 0.1 (Lane 2) or 1 
(Lane 3) µg of sense oligonucleotide; serum (Lane 4); or 0.1 (Lane 5) or 1 (Lane 6) 
µg of antisense oligonucleotide. 
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A-2. P2Y2 RECEPTOR ACTIVITY IS MODULATED BY THE ECTO- 
NUCLEOTIDASE NTPASE (CD39) 
Unpublished data; Gendron et al., (2002) Curr Drug Targets. (3):229-245. 
ABSTRACT 
Extracellular nucleotides initiate various cellular and physiological responses 
through P2 nucleotide receptors. Another important factor affecting extracellular 
nucleotide signaling is ecto-nucleoside triphosphate diphosphohydrolase (NTPDase; 
CD39) now considered as the main ecto-nucleotidase responsible for degrading tri- 
and diphosphonucleosides to monophosphate derivatives through sequential 
hydrolysis. Since the concentration and duration of extracellular nucleotides are key 
regulators of P2 nucleotide receptor function, the influence of ecto-nucleotidases is 
always considered as one of the major ways to modulate P2 receptor function. In the 
present studies, the NTPDase inhibitor BG0136 and several cell model systems 
including COS-7 cells, HEK cells and human 1321N1 astrocytoma cells stably 
transfected with P2Y2R cDNA were employed to understand the complex 
interrelationship between P2Y2 receptors and ecto-nucleotidases. Treatment with 350 
μM BG0136 resulted in a 30-50% decrease in UTP-stimulated ERK1/2 activity in 
COS-7, HEK cells and P2Y2R-transfected 1321N1 cells. In contrast, the COS-7/CD39 
cell transfectants demonstrated a decrease in UTP-stimulated inositol phosphate 
release compared to native COS-7 cells. The variable effects of BG0136 on P2Y2 
receptor signal propagation in cells expressing CD39 cDNA observed in our studies 
suggests that BG0136 may represent a new P2Y2R antagonist. 
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INTRODUCTION 
 
It was suggested that inhibition of the ecto-nucleotidases responsible for the 
hydrolysis of extracellular nucleotides could be an important factor in the modulation 
of purinergic signaling. This study concerns the inhibition of NTPDase and its 
possible impact on different physiological systems. Several enzymes are involved in 
the metabolism and control of extracellular nucleotide concentrations (Beaudoin et al., 
1996 & 2000; Gordon 1986; Zimmermann 1992 & 2000; Ziganshin et al., 1994; 
Plesner et al., 1995; Vlajkovic et al., 1998). The enzymes described above may also 
play an important role in the dephosphorylation of extracellular nucleotides 
(Zimmermann 2000; Beaudoin et al., 1996; Culic et al., 1990). In the past, 
modulation of nucleotide-induced cell signaling was focused on nucleotide receptors. 
Ecto-nucleotidases, more particularly the E-NTPDases family of ecto-enzymes, are 
now considered as potential new targets for P2 receptor modulation. Inhibition or 
modulation of E-NTPDases may prolong the effect of nucleotides at their respective 
receptors and/or modulate cell-to-cell interaction (Imai et al., 1999; Clifford et al., 
1997; Dzhandzhugazyan et al., 1998). New molecules have been synthesized to 
inhibit ecto-nucleotidases and particularly the E-NTPDases, such as P2 receptor 
agonists/antagonists and molecules related to the suramin-Evans blue families. Based 
on the structure-activity requirements, as described by Wittenburg et al. (Wittenburg 
et al., 1996), we report here the possible antagonistic property of BG0136 
(1-naphthol-3, 6-disulfonic acid, disodium salt) towards the P2Y2 receptor. 
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MATERIALS AND METHODS 
Materials  
Fetal bovine serum (FBS) was obtained from Hyclone (Logan, UT, USA). 
Dulbecco’s Modified Eagle’s medium (DMEM), penicillin (100 units/ml), and 
streptomycin (100 units/ml) were obtained from Gibco-BRL (Carlsbad, CA, USA). 
Rabbit anti-rat ERK1/2, horseradish peroxidase (HRP)-conjugated goat anti-rabbit 
IgG, and HRP-conjugated goat anti-mouse IgG antibodies were obtained from Santa 
Cruz Biotechnology (Santa Cruz, CA, USA). PERK antibody was obtained from Cell 
Signaling Technology (Beverly, MA, USA). The Precision Plus Protein Standards and 
nitrocellulose membranes (0.45 mm) were obtained from Bio-Rad (Hercules, CA, 
USA). LumiGLO chemiluminescent substrates were obtained from New England 
Biolabs (Beverly, MA, USA). Nucleotides and all other biochemicals were obtained 
from Sigma Chemical Co. (St. Louis, MO, USA). 
Cell Culture and Transfection 
Human 1321N1 astrocytoma cells (Parr et al., 1994), African Green Monkey 
Kidney Fibroblasts (COS-7 cells) and Human Embryonic Kidney (HEK) cells were 
cultured in DMEM (GIBCO BRL) containing 5% FBS, 100 U/ml penicillin, and 100 
µg/ml streptomycin. Cells were maintained at 37 °C in a humidified atmosphere of 
5% CO2 and 95% air. The retroviral vector, pLXSN, was used for stable expression of 
the P2Y2R construct in 1321N1 cells as described previously (Erb et al., 1995). In 
brief, the recombinant P2Y2R-pLXSN construct was used to transfect PA317 
amphotrophic packaging cells for production of viral vectors. Then, 1321N1 cells 
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were infected with the viral vectors and selected for neomycin resistance with 1 mg/ml 
G418 (GIBCO BRL). 
IP Assay 
To measure accumulation of IPs, COS-7 cells with or without expression of 
CD39 were plated in 12-well dishes and incubated in the presence or absence of the 
specified antibodies for 24 h in 0.7 ml serum-free and inositol-free DMEM containing 
2 µCi of [3H]-inositol (20 Ci/mmol). The cells were washed three times and incubated 
for 30 min at 37 °C in 1 ml of LiCl solution (15 mM glucose, 25 mM Hepes, 110 mM 
NaCl, 5 mM KCl, 1.8 mM CaCl2, 0.9 mM MgCl2, and 30 mM LiCl) followed by 
stimulation with 0.1 µM UTP for 10 min. The reactions were stopped by aspiration 
and cell extracts were obtained by addition of 0.3 ml of ice-cold 10% perchloric acid 
for 15 min. The extracts were neutralized with 0.6 ml of 2 M NaOH and 225 mM 
Hepes. The IPs in the neutralized extracts were separated from inositol and 
glycerophosphoinositol on Dowex columns, as described previously (Berridge et al., 
1983). Radioactivity in the IP fraction was determined by liquid scintillation 
spectrometry using Ecolume scintillation fluid.  
Western blot analysis 
Cells cultured in 6-well plates were treated with nucleotides in the presence or 
absence of inhibitors as indicated. The cells were washed twice with ice-cold PBS, 
and lysed for 5 min in 200 ml of ice-cold lysis buffer (20 mM Tris-HCl, pH 7.5, 2% 
(w/v) sodium dodecyl sulfate (SDS), and 1 mM sodium orthovanadate). Lysate (30 
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mg of protein) was added to Laemmli sample buffer (187.5 mM Tris-HCl, pH 6.8, 6% 
(w/v) SDS, 1.8% (v/v) β-mercaptoethanol and 0.003% (w/v) bromophenol blue). 
Samples were heated for 5 min at 96 °C, and subjected to 7.5% (w/v) 
SDS-polyacrylamide gel electrophoresis (SDS-PAGE) and transferred to 
nitrocellulose membranes for protein immunoblotting. After overnight blocking at 4 
°C with 5% (w/v) fat-free milk in TBS-T (10 mM Tris-HCl, pH 7.4, 120 mM NaCl, 
and 0.1% (v/v) Tween-20), membranes were incubated with either 1:1000 dilution of 
anti-ERK1/2 or anti-phospho-ERK1/2 antibodies for 2 h at room temperature, 
followed by incubation with HRP-conjugated anti-rabbit or anti-mouse IgG antibodies 
(1:1000 dilution in TBS-T containing 5% (w/v) fat-free milk) for 1 h at room 
temperature. Protein immunoreactivity was visualized on autoradiographic film using 
the LumiGlo Chemiluminescence System (New England BioLabs), according to the 
manufacturer’s instructions. The protein bands detected on X-ray film were quantified 
using a computer-driven scanner and Quantity One software (Bio-Rad, Hercules, CA). 
The activation levels of ERK1/2 were calculated as a percentage of control (i.e., total 
ERK1/2). 
RESULTS 
To determine the effect of CD39 on P2 nucleotide receptor-mediated signaling 
pathways, COS-7 and HEK cells were transfected with CD39. UTP-stimulated 
inositol phosphate release (Figure 1A) and ERK phosphorylation (Figure 1B and 2) 
were both inhibited in CD39-transfected COS-7 and HEK cells compared to 
untransfected cells, indicating that the expression and activation of E-NTPDase by 
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UTP inhibited UTP-stimulated P2Y2 nucleotide receptor signaling pathways. A 
recently developed compound, 1-hydroxynaphthalene-3, 6-disulfonic acid (BG0136) 
has been shown to inhibit bovine spleen NTPDase with a Ki of 350 μM. However, 
BG0136, the inhibitor of E-NTPDase also inhibited UTP-stimulated ERK 
phosphorylation in both CD39-transfected COS-7 and HEK cells (Figure 1B and 2), 
indicating the possible direct interaction of BG0136 with the P2Y2 nucleotide 
receptor.  
To investigate whether BG0136 could interact with P2 purinoceptors, human 
1321N1 astrocytoma cells which do not express endogenous P2Y2Rs were stably 
transfected with human P2Y2R. Pretreatment of cell transfectants with 350 μM 
BG0136 resulted in greater than 50% inhibition of ATP- and UTP- stimulated 
ERK1/2 phosphorylation in hP2Y2-1321N1 cells (Figure 3). Since this cell line has 
been found to have very little ectonucleotidase activity (Gendron et al., 2002), it 
appears that BG0136 could be either acting directly on the P2Y2 receptor or on some 
other component(s) in the ERK signaling pathway.  
Altogether, our results obtained with BG0136 and CD39-transfected COS-7, 
HEK and hP2Y2-1321N1 cells showed that transfection with ectonucleotidase inhibits 
UTP-stimulated signaling mediated by P2Y2 nucleotide receptors, including inositol 
phosphate release and ERK1/2 activation, whereas BG0136 inhibits 
UTP/ATP-stimulated ERK phosphorylation mediated by P2Y2Rs, possibly by acting 
as a P2Y2 receptor antagonist. Hence, even if BG0136 displays inhibitory activity 
towards E-NTPDase, it should be considered as a potential new P2Y2 nucleotide 
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receptor antagonist. However, further studies need to be done with this compound to 
determine its molecular specificity for P2 nucleotide receptor subtypes and 
ectonucleotidases. 
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Figure 1. Effect of BG0136 on UTP-stimulated inositol phosphate (IP) release 
and ERK1/2 activation in COS-7 cells with or without CD39 transfection. African 
Green Monkey Kidney Fibroblast (COS-7) Cells with (CD39/COS7) or without 
CD39 transfection were incubated with 350 μM BG0136 for 5 min at 37 oC, followed 
by stimulation with 10 μM UTP at 37 oC for the indicated time. IP release was 
measured by inositol assay and the phosphorylation of ERK1/2 was determined by 
Western blot analysis in which total ERK1/2 levels served as a loading control.
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Figure 2. Effect of BG0136 on UTP-stimulated ERK1/2 activation in HEK cells 
with or without CD39 transfection. Human Embryonic Kidney (HEK) cells with or 
without CD39 transfection were incubated with 350 μM BG0136 for 5 min at 37 oC, 
followed by stimulation with 10 μM UTP at 37 oC for the indicated time, and the 
phosphorylation of ERK1/2 was determined by Western blot analysis in which total 
ERK1/2 levels served as a loading control. 
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Figure 3. Effect of BG0136 on nucleotide-stimulated ERK activation in human 
1321N1 astrocytoma cells expressing the human P2Y2 nucleotide receptor. 
Human 1321N1 astrocytoma cells, stably transfected with the human P2Y2R cDNA, 
were incubated with 350 μM BG0136 for 5 min at 37 oC, followed by stimulation 
with 10 μM ATP or UTP at 37 oC for the indicated time. Phosphorylation of ERK1/2 
was determined by Western blot analysis in which total ERK levels served as a 
loading control.
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A-3. AN RGD SEQUENCE IN THE P2Y2 RECEPTOR INTERACTS WITH 
αVß3 INTEGRINS AND IS REQUIRED FOR Go-MEDIATED SIGNAL 
TRANSDUCTION 
Erb et al., (2001) J Cell Biol. 153(3):491-501. 
 
ABSTRACT 
The P2Y2 nucleotide receptor (P2Y2R) contains the integrin-binding domain 
arginine-glycine-aspartic acid (RGD) in its first extracellular loop, raising the 
possibility that this P2Y2R interacts directly with an integrin through its RGD domain. 
In this project, we tested whether an antibody raised against the αV integrin subunit 
could interfere with UTP-stimulated P2Y2R signal transduction such as inositol 
phosphates accumulation. Human 1321N1 cells expressing the P2Y2R were incubated 
in the presence or absence of specific anti-αV integrin antibody for 24 h in serum-free 
and inositol-free DMEM containing [3H]-inositol. Cells were then used to measure 
UTP-stimulated inositol phosphate (IP) release. The results indicate that overnight 
treatment with anti-αV antibody partially inhibits IP formation, consistent with the 
partial inhibition of UTP-induced FAK and ERK activation by anti-αV antibody and 
the decreased calcium response mediated by RGE mutant P2Y2Rs as compared to 
wild-type P2Y2Rs (Erb et al., 2001). In conclusion, these studies suggest that 
interaction of αV integrins with the P2Y2R is important for optimum P2Y2R 
activation. 
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INTRODUCTION 
As a G protein-coupled nucleotide receptor, activation of the P2Y2R stimulates 
PLC-dependent production of IP3 and DAG followed by calcium release and PKC 
activation. P2Y2Rs can also bind to growth factor receptors (GFRs) through 
SH3-binding domains in the C-terminal tail of the P2Y2R and cause transactivation 
of GFR signaling pathways. The present studies explore protein complex formation 
between integrins and the P2Y2 nucleotide receptor (P2Y2R), a Go- and Gq-coupled 
P2 nucleotide receptor subtype that is equipotently stimulated by ATP or UTP and 
mediates various cellular responses (Erb et al. 1993; Boarder et al. 1995). RGD has 
been found in various integrin ligands, (Clark and Brugge 1995; Frenette and 
Wagner 1996) as the core recognition sequence for many integrins, including αVß3, 
αVß5, αVß11, α5ß1, and αIIbß3 (Hynes 1992). Studies by Erb et al. (Erb et al., 2001) 
with P2Y2R-transfected cells indicated that a mutation of the RGD motif in the 
wild-type P2Y2R to RGE decreases receptor colocalization with αV integrins by 
10-fold and the RGE-mutant P2Y2R requires 1,000-fold higher agonist 
concentrations than the wild-type P2Y2R to phosphorylate FAK, activate ERK, and 
initiate the PLC-dependent mobilization of intracellular Ca2+. Furthermore, pertussis 
toxin, an inhibitor of Gi/o proteins, partially inhibited Ca2+ mobilization mediated by 
the wild-type P2Y2R, but not by the RGE mutant, suggesting that the RGD sequence 
is required for P2Y2R-mediated Go but not Gq activation. To address the possibility 
that the P2Y2R interacts with a specific integrin, here it was investigated whether an 
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antibody raised against the αV integrin subunit could interfere with UTP-stimulated 
P2Y2R signal transduction.  
MATERIALS AND METHODS 
Materials  
Fetal bovine serum (FBS) was obtained from Hyclone (Logan, UT, USA). 
Dulbecco’s Modified Eagle’s medium (DMEM), penicillin (100 units/ml), and 
streptomycin (100 units/ml) were obtained from Gibco-BRL (Carlsbad, CA, USA). 
Anti–human αV monoclonal antibody (mAb) was purchased from Zymed 
Laboratories. Anti–human α3 mAb was purchased from Santa Cruz Biotechnology, 
Inc. Nucleotides and all other biochemicals were obtained from Sigma Chemical Co. 
(St. Louis, MO, USA).  
Cell culture and transfection 
Human 1321N1 astrocytoma cells (Parr et al., 1994) were cultured in DMEM 
(GIBCO BRL) containing 5% FBS, 100 U/ml penicillin, and 100 µg/ml streptomycin. 
Cells were maintained at 37 °C in a humidified atmosphere of 5% CO2 and 95% air. 
The retroviral vector, pLXSN, was used for stable expression of the P2Y2R constructs 
in 1321N1 cells, as described previously (Erb et al., 1995). In brief, the recombinant 
P2Y2R-pLXSN construct was used to transfect PA317 amphotrophic packaging cells 
for production of the viral vectors. Then, 1321N1 cells were infected with the viral 
vectors and selected for neomycin resistance with 1 mg/ml G418 (GIBCO BRL). 
IP assay 
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To measure accumulation of IPs, 1321N1 cells expressing the P2Y2R were plated 
in 12-well dishes and incubated in the presence or absence of the specified antibodies 
for 24 h in 0.7 ml serum-free and inositol-free DMEM containing 2 µCi of 
[3H]-inositol (20 Ci/mmol). The cells were washed three times and incubated for 30 
min at 37 °C in 1 ml of LiCl solution (15 mM glucose, 25 mM Hepes, 110 mM NaCl, 
5 mM KCl, 1.8 mM CaCl2, 0.9 mM MgCl2, and 30 mM LiCl) followed by stimulation 
with 0.1 mM UTP for 10 min. The reactions were stopped by aspiration and cell 
extracts were obtained by addition of 0.3 ml of ice-cold 10% perchloric acid for 15 
min. The extracts were neutralized with 0.6 ml of 2 M NaOH and 225 mM Hepes. The 
IPs in the neutralized extracts were separated from inositol and 
glycerophosphoinositol on Dowex columns, as described previously (Berridge et al., 
1983). Radioactivity in the IP fraction was determined by liquid scintillation 
spectrometry using Ecolume scintillation fluid.  
RESULTS 
P2Y2R-mediated signaling is inhibited by anti-αV antibodies  
We investigated whether an antibody raised against the V integrin subunit 
could interfere with UTP-stimulated P2Y2R signal transduction. To analyze the 
effect of this antibody on the P2Y2R calcium signaling pathway, we measured IP 
formation since inositol 1, 4, 5-trisphosphate (IP3) is the second messenger for 
intracellular calcium mobilization (Weisman et al., 1998). The results indicated that 
overnight treatment with anti-αV antibody partially inhibited IP formation induced 
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by UTP (Figure 1), consistent with the decreased calcium response seen for the RGE 
mutant P2Y2 receptor as compared with the wild-type P2Y2R (data not shown; Erb 
et al., 2001). Anti- 3 integrin antibody had no effect on the ability of the P2Y2R to 
stimulate calcium signaling (Figure 1). These findings suggest that interaction of V 
integrin with the P2Y2R is important for optimum P2Y2R activation.  
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Figure 1. Effect of anti-integrin antibodies on P2Y2R-activated IP formation in 
1321N1 cells. Human 1321N1 cells expressing wild-type P2Y2Rs were incubated 
for 24 h with or without 100 µg/ml of the indicated antibody. The cells were then 
stimulated with 1 µM UTP for 10 min. Generation of IP is expressed as the 
percentage of maximum stimulation with UTP after background subtraction 
(backgrounds for control, α3-treated, and αV-treated samples were 18,462 ± 1,090, 
15,670 ± 1,000, and 30,450 ± 3,650 dpm, respectively).
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